Education and Career

Education

•   1979 04  - 1985 03 , Kyoto University Faculty of Medicine
•   1989 04  - 1993 03 , Kyoto University Graduate School of Medicine, Internal Medicine System

Academic & Professional Experience

•   2005 10 ,  - 現在, Professor, Department of Radiology, Kindai University Faculty of Medicine
•   2003 04 ,  - 2005 09 , Associate Professor, Department of Radiology, Kindai University Faculty of Medicine
•   1995 10 ,  - 2003 04 , Lecturer, Department of Radiology, Saitama Medical University
•   1994 10 ,  - 1995 09 , Research Fellow, INSERM U211, Nantes University, French Government Research Fellowship
•   1993 10 ,  - 1994 09 , Humboldt Foundation Research Fellow, Bonn University Department of Nuclear Medicine, Humboldt Foundation Research Fellowship
•   1993 04 ,  - 1993 09 , Fellow, Department of Radiology and Nuclear Medicine, Kyoto University Hospital
•   1986 04 ,  - 1989 03 , Fellow, Department of Radiology, Kitano Hospital (Osaka)
•   1985 04 ,  - 1986 03 , Resident, Department of Radiology and Nuclear Medicine, Kyoto University Hospital

Research Activities

Research Areas

• Life sciences, Radiology

Research Interests

• Nuclear Oncology, Targeted Molecular Therapy, Molecular Imaging, tumor targeting, Radiological Protection

Published Papers

• Trends in Medical Exposure, HOSONO Makoto, Journal of Kyoto Prefectural University of Medicine, Journal of Kyoto Prefectural University of Medicine, 129(2), 153 - 157, Feb. 2020 , Refereed
• Evolution of PET in Japan from Viewpoint of 16-years' Surveys, Makoto Hosono, Kengo Ito, Isotope News, Isotope News, (767), 16 - 19, Feb. 2020
• A Multicenter Prospective Observational Study Protocol for Radiation Exposure from Gastrointestinal Fluoroscopic Procedures (REX-GI study), Nishida T, Hayashi S, Takenaka M, Hosono M, Kogure H, Hasatani K, Yamaguchi S, Maruyama H, Doyama H, Ihara H, Yoshio T, Nagaike K, Yamada T, Yakushijin T, Takagi T, Tsumura H, Kurita A, Asai S, Ito Y, Kuwai T, Hori Y, Maetan I, Ikezawa K, Iwashita T, Matsumoto K, Inada M, BMJ Open, BMJ Open, 10(e033604), 1 - 8, Feb. 2020 , Refereed
  DOI
• A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study, Matsubara N, Kimura G, Uemura H, Uemura H, Nakamura M, Nagamori S, Mizokami A, Kikukawa H, Hosono M, Kinuya S, Krissel H, Siegel J, Yoshiyuki Kakehi Y, Int J Clin Oncol, Int J Clin Oncol, in press, 2020 , Refereed
• Current status of radiation exposure to crystalline lens in ERCP (endoscopic retrograde cholangiopancreatography), Mamoru Takenaka, Makoto Hosono, Atsushi Nakai, Shunsuke Omoto, Kosuke Minaga, Ken Kamata, Kentaro Yamao, Shiro Hayashi, Tsutomu Nishida, Masatoshi Kudo, Journal of Japanese Society of Gastroenterology, Journal of Japanese Society of Gastroenterology, 116(12), 1053 - 1055, Dec. 2019 , Refereed
  DOI
• Prospects of personalized medicine through theranostics, HATAZAWA Jun, HOSONO Makoto, Japanese Journal of Clinical Radiology, Japanese Journal of Clinical Radiology, 64(13), 1495 - 1495, Dec. 2019
• Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials, Hosono M, Ikebuchi H, Kinuya S, Yanagida S, Nakamura Y, Yamada T, Sakaguchi K, Sugano H, Kojima K, Hatazawa J, Ann Nucl Med, Ann Nucl Med, 33(11), 787 - 505, Nov. 2019 , Refereed
• A sight-visit report on the radiation safety managements in the University of Gothenburg, NAGATSU K, UKON N, YAMADA T, HOSONO M, Japanese Journal of Radiation Safety Management, Japanese Journal of Radiation Safety Management, 18(2), 36 - 40, Nov. 2019 , Refereed
  DOI
• Radiation protection in therapy with radiopharmaceuticals, HOSONO Makoto, International Journal of Radiation Biology, International Journal of Radiation Biology, 95(10), 1427 - 1430, Oct. 2019 , Refereed
• Radiological protection in therapy with radiopharmaceuticals, Yonekura Y, Mattsson S, Flux G, Bolch WE, Dauer LT, Fisher DR, Lassmann M, Palm S, Hosono M, Doruff M, Divgi C, Zanzonico P, Ann ICRP, Ann ICRP, 48(1), 5 - 95, Oct. 2019 , Refereed
  DOI
• Quantitative measurement of 219Rn radioactivity in exhaled breath from patients with bone metastasis of castration-resistant prostate cancer treated with 223RaCl2, Ooe K, Watabe T, Kamiya T, Yoshimura T, Hosono M, Shinohara A, Hatazawa J, EJNMMI Physics, EJNMMI Physics, 6(13), 1 - 11, Jul. 2019 , Refereed
  DOI
• EXAMINATION OF ACTUAL RADIATION EXPOSURE DOSE OF THE PATIENTS WHO PERFORMED EUS-GUIDED DRAINAGE (EUS-BD/EUS-PD/EUS-CD), Takenaka Mamoru, Hayashi Shiro, Nishida Tsutomu, Hosono Makoto, Yoshikawa Tomoe, Ishikawa Rei, Okamoto Ayana, Yamazaki Tomohiro, Nakai Atsushi, Omoto Shunsuke, Minaga Kosuke, Kamata Ken, Yamao Kentaro, Kudo Masatoshi, GASTROINTESTINAL ENDOSCOPY, GASTROINTESTINAL ENDOSCOPY, 89(6), AB444 - AB445, Jun. 2019 , Refereed
  DOI
• Involvement of costal cartilage in relapsing polychondritis detected by 18F-FDG PET/CT, Fukumoto G, Hosono M, Kanagaki M, Ichinose M, Nishisaka K, Japanese Archive of Cases Conference of Clinical Nuclear Medicine, Japanese Archive of Cases Conference of Clinical Nuclear Medicine, 1, 23 - 27, Jun. 2019 , Refereed
  DOI
• Evaluation and optimization of new PET reconstruction algorithm Bayesian penalized likelihood reconstruction in lung cancer according to lesion size, Otani T, Hosono M, Kanagaki M, Oka S, Fukumoto G, Onishi Y, Matsubara N, Kawabata K, Kimura H, American J Roentgenology, American J Roentgenology, 213(2), W50 - W56, Jun. 2019 , Refereed
  DOI
• Perspectives for concepts of individualized radionuclide therapy, molecular radiotherapy, and theranostic approaches, HOSONO Makoto, Nuclear Medicine and Molecular Imaging, Nuclear Medicine and Molecular Imaging, 53(3), 167 - 171, Jun. 2019 , Refereed
• Rapid progression of metastatic pulmonary calcification diagnosed by 99mTc-MDP scintigraphy, Fukumoto G, Hosono M, Kanagaki M, Otani T, Ikegaki S, Japanese Archive of Cases Conference of Clinical Nuclear Medicine, Japanese Archive of Cases Conference of Clinical Nuclear Medicine, 1, 17 - 22, May 2019 , Refereed
  DOI
• Projects for revision of DRLs in nuclear medicine and prospects, HOSONO Makoto, Innervision, Innervision, 34(3), 32 - 33, Mar. 2019
• Introduction of the targeted alpha therapy (with Radium-223) into clinical practice in Japan: learnings and implementation, Hosono M, Ikebuchi H, Nakamura Y, Yanagida S, Kinuya S, Annals of Nuclear Medicine, Annals of Nuclear Medicine, 33(3), 211 - 221, Mar. 2019 , Refereed
  DOI
• Significance and application of diagnostic reference level in ICRP recommendation (Explanation of Pub.135), HOSONO Makoto, Radiation Effects Association, Radiation Effects Association, 10(97), 21 - 22, Oct. 2018
• Proposal of Criteria for Release of Patients and Use of the Normal Ward in 64Cu-ATSM Internal Radiotherapy, Yukie Yoshii, Mitsuyoshi Yoshimoto, Tatsuya Higashi, Makoto Hosono, Kakuigaku, Kakuigaku, 55(1), 77 - 87, Jul. 2018 , Refereed
  DOI
• Impact to Z-score Mapping of Hyperacute Stroke Images by Computed Tomography in Adaptive Statistical Iterative Reconstruction, Watanabe Shota, Sakaguchi Kenta, Hosono Makoto, Ishii Kazunari, Murakami Takamichi, Ichikawa Katsuhiro, Japanese Journal of Radiological Technology, Japanese Journal of Radiological Technology, 74(4), 375 - 381, Apr. 2018 , Refereed
  DOI
• Resistance to ibritumomab, HOSONO Makoto, CHATAL Jean-François, Resistance to Targeted Anti-Cancer Therapeutics, Resistance to Targeted Anti-Cancer Therapeutics, 1 - 158, Apr. 2018 , Refereed
• Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.), Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yamada T, Yanagida S, Kitaoka A, Kojima K, Sugano H, Kinuya S, Inoue T, Hatazawa J, Annals of Nuclear Medicine, Annals of Nuclear Medicine, 32(3), 217 - 235, Apr. 2018 , Refereed
  DOI
• 孤立性内臓動脈解離のCT所見, 福井秀行, 松木充, 任誠雲, 甲斐田勇人, 柳生行伸, 小塚健倫, 細川知紗, 熊野正士, 柏木伸夫, 鶴崎正勝, 今岡いずみ, 細野眞, 石井一成, 村上卓道, Japanese Journal of Radiology, Japanese Journal of Radiology, 36(Supplement), 34, Feb. 25 2018
• 神経核内封入体病の1例, 沼本勲男, 松木充, 福井秀行, 若林雄一, 日高正二郎, 渡口真史, 藤谷哲也, 山川美帆, 兵頭朋子, 山田穣, 任誠雲, 甲斐田勇人, 柳生行伸, 柏木伸夫, 細川知紗, 小塚健倫, 鶴崎正勝, 今岡いずみ, 細野眞, 石井一成, 村上卓道, Japanese Journal of Radiology, Japanese Journal of Radiology, 36(Suppl.), 27 - 27, Feb. 2018 , Refereed
• Radiation exposure during image-guided endoscopic procedures: The next quality indicator for endoscopic retrograde cholangiopancreatography, Hayashi S, Takenaka M, Hosono M, Nishida T, World Journal of Clinical Cases, World Journal of Clinical Cases, 6(16), 1087 - 1093, 2018 , Refereed
  DOI
• 前立腺癌における骨のマネージメント 前立腺癌骨転移に対するRa‐223の基礎, 細野眞, 細野眞, 泌尿器外科, 泌尿器外科, 30(10), 1521‐1526, Oct. 15 2017
• Basics of radium-223 for treatment of prostate cancer with bone metastasis, HOSONO Makoto, hinyoki-geka, hinyoki-geka, 30(10), 1521 - 1526, Oct. 2017
• Features of Alpha Targeted Therapy and History of Development for Ra-223, HOSONO Makoto, Pharma Medica, Pharma Medica, 35(9), 96 - 101, Sep. 20 2017
• Ra‐223の臨床応用について, 細野眞, 日本医学放射線学会秋季臨床大会抄録集, 日本医学放射線学会秋季臨床大会抄録集, 53回, S435 - S436, Aug. 2017 , Refereed
• 興味深いFDG‐PET/CT所見を示した小児の後腹膜腫瘍の1例, 大西康之, 細野眞, 金柿光憲, 福本元気, 尾谷知亮, 松原菜穂子, 木村弘之, 核医学症例検討会症例集, 核医学症例検討会症例集, 38(2), 41, Aug. 2017
• Q.Freezeが有用であった肺腺がん肝転移の1例, 藤井康司, 白髭賢也, 竹中達明, 細野眞, 核医学症例検討会症例集, 核医学症例検討会症例集, 38(2), 31‐32, Aug. 2017
• A new shielding calculation method for X-ray computed tomography regarding scattered radiation., Watanabe H, Noto K, Shohji T, Ogawa Y, Fujibuchi T, Yamaguchi I, Hiraki H, Kida T, Sasanuma K, Katsunuma Y, Nakano T, Horitsugi G, Hosono M, Radiological physics and technology, Radiological physics and technology, 10(2), 213 - 226, Jun. 2017 , Refereed
  DOI
• PET検診の総括から未来へ はじめに, HOSONO Makoto, 62, 619 - 612, May 2017 , Refereed
• CRPC治療におけるRa-223の位置付け, 赤座 英之, 酒井 英樹, 米田 俊之, 細野 眞, 和久本 芳彰, 泌尿器外科, 泌尿器外科, 30(4), 409 - 416, Apr. 2017
• アルファ線核種の臨床利用における法令と指針, 細野眞, 日本放射線技術学会総会学術大会予稿集, 日本放射線技術学会総会学術大会予稿集, 73rd, 112, Mar. 21 2017
• 4D‐CTを用いた呼吸同期撮像法の有用性, 藤井康司, 白髭賢也, 竹中達明, 細野眞, 日本放射線技術学会総会学術大会予稿集, 日本放射線技術学会総会学術大会予稿集, 73rd, 302, Mar. 21 2017
• 前立腺小線源療法後1年以内死亡の3例, 横川正樹, 中松清志, 稲田正浩, 福田浩平, 建部仁志, 石川一樹, 立花和泉, 門前一, 金森修一, 西村恭昌, 細野眞, Japanese Journal of Radiology, Japanese Journal of Radiology, 35(Suppl.), 51 - 51, Feb. 2017
• アイソトープ治療の現状と展望 アルファ核種の利用, 細野 眞, Japanese Journal of Radiology, Japanese Journal of Radiology, 35(Suppl.), 45 - 45, Feb. 2017
• Estimation of activity of administered ¹⁸F-fluorodeoxyglucose by measurement of the dose equivalent rate on the right temporal region of the head., Sakaguchi K, Hosono M, Imamura T, Takahara N, Hayashi M, Yakushiji Y, Ishii K, Uto T, Murakami T, EJNMMI physics, EJNMMI physics, 3(1), 28, Dec. 2016 , Refereed
  DOI
• 医療被ばくの正当化と最適化に向けて Part II II 診断参考レベル(DRL)に対する活動と課題 3.核医学検査の診断参考レベル(DRL)に対する活動と課題, 細野眞, Innervision, Innervision, 31(12), 12‐14, Nov. 25 2016
• 医療被ばくの正当化と最適化に向けて Part II 医療被ばく管理と放射線防護の現状と将来展望, 細野眞, Innervision, Innervision, 31(12), 2‐4, Nov. 25 2016
• 【医療被ばくの正当化と最適化に向けてPart II】 診断参考レベル(DRL)に対する活動と課題 核医学検査の診断参考レベル(DRL)に対する活動と課題, 細野 眞, INNERVISION, INNERVISION, 31(12), 12 - 14, Nov. 2016
  Summary:医療放射線に関連した学会・団体が、医療被ばく研究情報ネットワーク(Japan Network for Research and Information on Medical Exposure:J-RIME)の枠組みにて協働して診断参考レベルの設定に取り組み、2015年6月7日に「診断参考レベル2015(Japan DRLs 2015)」(以下、DRLs2015)を公表した。これに含まれる6つのモダリティの1つに核医学検査がある。核医学検査の診断参考レベルは、全国のすべての核医学診療施設を対象にして調査を実施し、その集計結果に基づいて「実投与量」として設定したものである。また、小児の核医学検査における放射性薬剤の適正投与量の設定も重要な課題であった。これについては、診断参考レベルとは別の概念に基づいて検討され、「小児核医学検査適正施行のコンセンサスガイドライン」に示された。したがって、現在、成人の適正投与量についてはDRLs2015、小児の適正投与量については「小児核医学検査適正施行のコンセンサスガイドライン」に規定されている仕組みとなっており、この2つの適正投与量とその内容を十分に理解して核医学検査を実施することが要である。これらの適正投与量が公表(2013〜2015年)された後、関連した学会・団体は学術集会、機関誌、Webサイトなどを通じてその普及に努めている。(著者抄録)
• 分子標的RIがん治療の新展開 国内のRI治療の問題点と解決のための提言, 東 達也, 池渕 秀治, 内山 眞幸, 織内 昇, 絹谷 清剛, 細野 眞, 日本癌治療学会学術集会抄録集, 日本癌治療学会学術集会抄録集, 54回, S18 - 2, Oct. 2016
• Theranostics:イメージングと治療の融合, 細野眞, 核医学技術, 核医学技術, 36, 386, Sep. 30 2016
• 肺血流MAAシンチグラフィにおいて投与時の体位によりシャント率が変化した1例, 渡邊翔太, 坂口健太, 黒川敏昭, 小西達郎, 吉田修平, 又野嘉枝子, 細野眞, 核医学症例検討会症例集, 核医学症例検討会症例集, 37(1), 3‐4, Aug. 2016
• Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan., Watanabe H, Ishii K, Hosono M, Imabayashi E, Abe K, Inubushi M, Ohno K, Magata Y, Ono K, Kikuchi K, Wagatsuma K, Takase T, Saito K, Takahashi Y, Annals of nuclear medicine, Annals of nuclear medicine, 30(6), 435 - 444, Jul. 2016 , Refereed
  DOI
• 診断参考レベル(DRLs)の国内導入, 細野眞, 近畿大学医学雑誌, 近畿大学医学雑誌, 41(1-2), 3‐7, Jun. 23 2016
• Myocardial changes on FDG-PET/CT after radiation therapy for esophageal cancer., 稲田正浩, 西村恭昌, 石川一樹, 花岡宏平, 坂口健太, 細野眞, 臨床放射線, 臨床放射線, 61(5), 657‐666 - 666, May 10 2016
  DOI
• Pretherapeutic FDG heterogeneity in tumors can predict local control in oropharyngeal cancer patients undergoing intensity-modulated radiation therapy, Hanaoka Kohei, Hosono Makoto, Tatebe Hitoshi, Ishikawa Kazuki, Monzen Hajime, Ishii Kazunari, Nishimura Yasumasa, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 57, May 01 2016 , Refereed
• Texture analysis for FMISO PET/CT in oncology patients receiving extra-beam radiation therapy, Hosono Makoto, Tachibana Izumi, Nishimura Yasumasa, Hanaoka Kohei, Sakaguchi Kenta, Ishikawa Kazuki, Nakamatsu Kiyoshi, Kanamori Shuichi, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 57, May 01 2016 , Refereed
• アイソトープ治療の現状と展望, 細野眞, FB News, FB News, (473), 1 - 3, May 01 2016
• 診断参考レベルの国内導入, 細野眞, 日本診療放射線技師会誌, 日本診療放射線技師会誌, 63(4), 403‐405, Apr. 01 2016
• 医療における放射線防護と関連法令整備に関する研究 水晶体線量の評価手法に関する研究, 坂口健太, 赤羽正章, 薬師寺優子, 高原尚美, 花岡宏平, 細野眞, 医療における放射線防護と関連法令整備に関する研究 平成27年度 総括・分担研究報告書, 医療における放射線防護と関連法令整備に関する研究 平成27年度 総括・分担研究報告書, 162‐166, 2016
• 医療における放射線防護と関連法令整備に関する研究 放射性医薬品(放射性塩化ラジウム(²²³RaCl₂)注射液)を投与された患者の退出基準について, 細野眞, 池渕秀治, 上田いづみ, 北岡麻美, 坂口健太, 中村伸貴, 中村吉秀, 花岡宏平, 柳田幸子, 山田崇裕, 医療における放射線防護と関連法令整備に関する研究 平成27年度 総括・分担研究報告書, 医療における放射線防護と関連法令整備に関する研究 平成27年度 総括・分担研究報告書, 9‐30, 2016
• Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition, Ishii K, Hosokawa C, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, Hosono M, Yamazoe Y, Murakami T, Nuclear Medicine In Clinic, Nuclear Medicine In Clinic, 49(6), 89 - 90, 2016 , Refereed
• Radioisotope Therapy of Japan: Future Perspective and Recommendations., Higashi T, Ikebuchi S, Uchiyama M, Oriuchi N, Kinuya S, Hosono M, Kaku igaku. The Japanese journal of nuclear medicine, Kaku igaku. The Japanese journal of nuclear medicine, 53(1), 27 - 43, 2016 , Refereed
  DOI
• Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images., Hosokawa C, Ishii K, Kimura Y, Hyodo T, Hosono M, Sakaguchi K, Usami K, Shimamoto K, Yamazoe Y, Murakami T, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56(12), 1910 - 1915, Dec. 2015 , Refereed
  DOI
• Feasibility of heterogeneity analysis for intratumoral hypoxia on FMISO PET/CT in radiation therapy, Hosono Makoto, Tachibana Izumi, Nishumura Yasumasa, Hanaoka Kohei, Kanamori Shuichi, Nakamatsu Kiyoshi, Ishikawa Kazuki, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 56(3), May 01 2015 , Refereed
• Radiation exposure of nursing staff in PET practices in correlation to performance status of patients, Hosono Makoto, Takahara Naomi, Yakushiji Yuuko, Sakaguchi Kenta, Ishii Kazunari, JOURNAL OF NUCLEAR MEDICINE, JOURNAL OF NUCLEAR MEDICINE, 56(3), May 01 2015 , Refereed
• Heterogeneity of intratumoral (111)In-ibritumomab tiuxetan and (18)F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin's lymphoma., Hanaoka K, Hosono M, Tatsumi Y, Ishii K, Im SW, Tsuchiya N, Sakaguchi K, Matsumura I, EJNMMI research, EJNMMI research, 5, 10, Mar. 14 2015 , Refereed
  DOI
• 医療における放射線防護と関連法令整備に関する研究 がんの骨転移及び原発性骨腫瘍等の治療に用いられる放射性ラジウム‐223の有効性及び投与された患者の管理区域からの退出などの放射線防護対策について, 細野眞, 宇佐美公男, 坂口健太, 花岡宏平, 上田いづみ, 池渕秀治, 中村吉秀, 中村伸貴, 山田崇裕, 柳田幸子, 北岡麻美, 医療における放射線防護と関連法令整備に関する研究 平成26年度 総括・分担研究報告書, 医療における放射線防護と関連法令整備に関する研究 平成26年度 総括・分担研究報告書, 1‐3,5‐38, 2015
• Applicability of self-activation of an NaI scintillator for measurement of photo-neutrons around a high-energy X-ray radiotherapy machine., Wakabayashi G, Nohtomi A, Yahiro E, Fujibuchi T, Fukunaga J, Umezu Y, Nakamura Y, Nakamura K, Hosono M, Itoh T, Radiological physics and technology, Radiological physics and technology, 8(1), 125 - 134, Jan. 2015 , Refereed
  DOI
• Investigation of ¹¹C-PiB equivocal PET findings., Hosokawa C, Ishii K, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, Yamazoe Y, Hosono M, Hanada K, Ueda M, Saigo K, Murakami T, Annals of nuclear medicine, Annals of nuclear medicine, 29(2), 164 - 169, Nov. 2014 , Refereed
  DOI
• Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition., Ishii K, Hosokawa C, Hyodo T, Sakaguchi K, Usami K, Shimamoto K, Hosono M, Yamazoe Y, Murakami T, Annals of nuclear medicine, Annals of nuclear medicine, 29(1), 78 - 83, Oct. 2014 , Refereed
  DOI
• 医療放射線防護に関する研究 国際動向に関する研究,核医学領域における放射線防護に関する研究 核医学診療施設における濃度限度等の評価に関する検討について, 細野眞, 池渕秀治, 中村吉秀, 中村伸貴, 山田崇裕, 柳田幸子, 北岡麻美, 宇佐美公男, 坂口健太, 花岡宏平, 上田いづみ, 医療放射線防護に関する研究 平成25年度 総括・分担研究報告書, 医療放射線防護に関する研究 平成25年度 総括・分担研究報告書, HOSONO,25-76, 2014
• 医療放射線防護に関する研究 災害等による事故の場合の措置や事故防止に関する検討 放射線診療部門での災害への備えに関する検討, 細野眞, 山口一郎, 小高喜久雄, 佐藤幸光, 奥山康男, 平出博一, 遠山尚紀, 医療放射線防護に関する研究 平成25年度 総括・分担研究報告書, 医療放射線防護に関する研究 平成25年度 総括・分担研究報告書, YAMAGUCHI,15-30, 2014
• 医療放射線防護に関する研究 災害等による事故の場合の措置や事故防止に関する検討 CT装置の放射線事前安全の合理的評価法開発, 細野眞, 山口一郎, 小川泰良, 笹沼和智, 庄司友和, 中野拓郎, 能登公也, 平出博一, 藤淵俊王, 渡邉浩, 医療放射線防護に関する研究 平成25年度 総括・分担研究報告書, 医療放射線防護に関する研究 平成25年度 総括・分担研究報告書, YAMAGUCHI,1-13, 2014
• A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity, Arano Y, Matsushima H, Tagawa M, Inoue T, Koizumi M, Hosono M, Sakahara H, Endo K, Konishi J, Yokoyama A, Nucl Med Biol, Nucl Med Biol, 21, 63 - 69, 2014 , Refereed
• A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy., Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Koike R, Nishikawa T, Ishikawa K, Tamura M, Hosono M, Journal of radiation research, Journal of radiation research, 54(6), 1078 - 1084, Nov. 2013 , Refereed
  DOI
• Measurements for a Contamination Control of a ^<223>Ra Medicament, HOHARA Sin-ya, HOSONO Makoto, INAGAKI Masayo, IM Sung-Woon, MORIMOTO Hideo, HANAOKA Kohei, SAKAGUCHI Kenta, YAMANISHI Hirokuni, ITOH Tetsuo, RADIOISOTOPES, RADIOISOTOPES, 62(9), 659 - 665, Sep. 15 2013
  Summary:In recent years, attention has been focused on radionuclide therapy with &alpha; emission nuclides. Research and clinical tests of pharmaceuticals including ²²³Ra, which has short half-life and a number of &alpha; & &beta; decays with its decay family, started in Japan in this year. Despite the fact that research on pharmaceuticals including ²²³Ra is continuing, methods and knowledge of ²²³Ra radiation controls have not been researched.<br>Contamination controls of radioactive pharmaceuticals in clinical sites are very important because of radiation protection, and research on ²²³Ra-contamination controls should be performed as soon as possible before any medical application becomes licensed.<br>In this work, we performed demonstration experiments of ²²³Ra-contamination with commonly-used survey meters. The results of experiments show that a Geiger-Muller type survey meter(TGS-133:Hitachi Aloka Medical) is effective to find ²²³Ra-contamination, but an NaI(Tl) scintillation type survey meter(TCS-161:Hitachi Aloka Medical) should be used carefully due to the measurement limit in a ²²³Ra-contamination survey.
  DOI
• 医療放射線防護に関する厚生労働省班研究の概要, 細野 眞, 山口 一郎, 高橋 健夫, 赤羽 正章, 成田 雄一郎, 池渕 秀治, 中村 吉秀, 柳田 幸子, 中村 伸貴, 山田 崇裕, 日本医学放射線学会学術集会抄録集, 日本医学放射線学会学術集会抄録集, 72回, S162 - S162, Feb. 2013
• 医療放射線防護に関する研究 国際動向に関する研究,核医学領域における放射線防護に関する研究 塩化ラジウム(Ra‐223)注射液の使用に当たって実施する放射線管理のための遮へい計算並びに空気中及び排気・排水中の放射能濃度の計算方法について, 細野眞, 宇佐美公男, 花岡宏平, 上田いづみ, 池渕秀治, 中村吉秀, 中村伸貴, 山田崇裕, 柳田幸子, 北岡麻美, 医療放射線防護に関する研究 平成24年度 総括・分担研究報告書, 医療放射線防護に関する研究 平成24年度 総括・分担研究報告書, 38 - 63, 2013
• ¹¹¹In‐ゼバリンSPECT/CTで腫瘍活性残存を検出できた非ホジキンリンパ腫の一例, 米矢吉宏, 細野眞, 山田穣, 松木充, 花岡宏平, 坂口健太, 任誠雲, 柳生行伸, 石井一成, 辰巳陽一, 松村到, 土屋典生, 核医学, 核医学, 49(4), 439, Nov. 30 2012
• Guidelines for clinical use of FDG PET, PET/CT 2012, 細野 眞, 佐賀 恒夫, 伊藤 健吾, 汲田 伸一郎, 佐々木 雅之, 千田 道雄, 畑澤 順, 渡邉 浩, 伊藤 浩, 金谷 信一, 木村 裕一, 佐治 英郎, 陣之内 正史, 福喜多 博義, 村上 康二, 絹谷 清剛, 山崎 純一, 内山 眞幸, 宇野 公一, 加藤 克彦, 川野 剛, 日下部 きよ子, 窪田 和雄, 戸川 貴史, 本田 憲業, 丸野 廣大, 吉村 真奈, 宍戸 文男, 井上 登美夫, 福田 寛, 中村 佳代子, Jpn J Nucl Med (Kaku Igaku), Jpn J Nucl Med (Kaku Igaku), 49(4), 391 - 401, Nov. 30 2012
• Gamut of FDG-PET, 御前 隆, 石津 浩一, 石守 崇好, 工藤 崇, 中本 裕士, 東 達也, 細野 眞, 核医学 : 日本核医学会機関誌 : the Japanese journal of nuclear medicine, 核医学 : 日本核医学会機関誌 : the Japanese journal of nuclear medicine, 49(4), 357 - 389, Nov. 30 2012
• Dynamic sequence respiratory gated perfusion pulmonary SPECT without external tracking device., Sakaguchi K, Hosono M, Otsuka M, Hanaoka K, Usami K, Uto T, Ishii K, Annals of nuclear medicine, Annals of nuclear medicine, 27(1), 65 - 73, Oct. 2012 , Refereed
  DOI
• Recognition of complete response by long-term observation after treatment with 90Y-Ibritumomab tiuxetan for relapsed follicular lymphoma, Acta Med Kinki Univ, Acta Med Kinki Univ, 36(2), 87 - 89, Sep. 2012
• Recognition of complete response by long-term observation after treatment with 90Y-Ibritumomab tiuxetan for relapsed follicular lymphoma, Tatsumi Y, Rai S, Shimada T, Yamaguchi K, Morita Y, Kawanishi K, Miyatake J, Ashida T, Hosono M, Matsumura I, Acta Med Kinki Univ, Acta Med Kinki Univ, 36(2), 87 - 89, Sep. 2012 , Refereed
• 内用療法の環境整備, 細野眞, 核医学, 核医学, 49(3), 164, Aug. 31 2012
• 認知症における脳FDG‐PET早期撮像の可能性について, 兵頭朋子, 石井一成, 坂口健太, 花岡宏平, 宇佐美公男, 島元健次, 山添譲, 山田穣, 松木充, 細野眞, 村上卓道, 核医学, 核医学, 49(3), 294, Aug. 31 2012
• SPECT/CTを用いたバセドウ病のヨウ素131治療計画, 細野眞, 花岡宏平, 米矢吉宏, 土屋典生, 坂口健太, 高田裕史, 森元英夫, 宇佐美公男, 石井一成, 核医学症例検討会症例集, 核医学症例検討会症例集, 33(1), 15-16, Aug. 2012
• Impact of CT attenuation correction by SPECT/CT in brain perfusion images., Ishii K, Hanaoka K, Okada M, Kumano S, Komeya Y, Tsuchiya N, Hosono M, Murakami T, Annals of nuclear medicine, Annals of nuclear medicine, 26(3), 241 - 247, Apr. 2012 , Refereed
  DOI
• 医療放射線の安全確保と有効利用に関する厚生労働省班研究の概要, 細野眞, 岡野友宏, 山口一郎, 高橋健夫, 赤羽正章, 雫石一也, 池渕秀治, 柳田幸子, 米矢吉宏, 土屋典生, 日本医学放射線学会総会抄録集, 日本医学放射線学会総会抄録集, 71st, S150, Feb. 29 2012
• ¹³¹I甲状腺内用療法におけるSPECT/CTを用いた甲状腺重量測定について, 花岡宏平, 大塚正和, 吉田修平, 井上亮, 石井一成, 村上卓道, 細野眞, 日本放射線技術学会総会学術大会予稿集, 日本放射線技術学会総会学術大会予稿集, 68th, 185-186, Feb. 29 2012
• 脳FDG集積低下を示す大きな腫瘍代謝症例の分析, 細野眞, 花岡宏平, 米矢吉宏, 土屋典生, 宇佐美公男, 高田裕史, 坂口健太, 森元英夫, IM Sung‐Woon, 石井一成, 辰巳陽一, 下野太郎, 核医学症例検討会症例集, 核医学症例検討会症例集, 32(2), 41-42, Feb. 2012
• 医療放射線の安全確保と有効利用に関する研究 医療現場における医療放射線の安全管理体制に関する指針等についての調査研究, 細野眞, 山口一郎, 藤田真紀, 清堂峰明, 医療放射線の安全確保と有効利用に関する研究 平成22-23年度 総合研究報告書, 医療放射線の安全確保と有効利用に関する研究 平成22-23年度 総合研究報告書, YAMAGUCHI,1-19, 2012
• 医療放射線の安全確保と有効利用に関する研究 医療現場における医療放射線の安全管理体制に関する指針等についての調査研究, 細野眞, 山口一郎, 藤田真紀, 清堂峰明, 医療放射線の安全確保と有効利用に関する研究 平成23年度 総括・分担研究報告書, 医療放射線の安全確保と有効利用に関する研究 平成23年度 総括・分担研究報告書, YAMAGUCHI,1-9, 2012
• 〈Case Reports〉Recognition of complete response by long-term observation after treatment with ^<90>Y-Ibritumomab tiuxetan for relapsed follicular lymphoma, Tatsumi Yoichi, Rai Shinya, Shimada Takahiro, Yamaguchi Terufumi, Morita Yasuhiro, Kawanishi Kazunobu, Miyatake Junichi, shida Takashi, Maeda Yasuhiro, Hosono Makoto, Matsumura Itaru, Acta Medica Kinki University, Acta Medica Kinki University, 36(2), 87 - 89, Dec. 01 2011
  Summary:[Abstract] Monoclonal antibodies have markedly changed the treatment possibilities for patients with indolent B-cell lymphoma. ^<90>Y-Ibritumomab tiuxetan (Zevalin) is the first radioimmunotherapy (RIT) agent approved for the treatment of relapsed and refractory indolent lymphoma patients. In most cases, the maximum clinical response were observed two to three months after RIT. Treatment with ^<90>Y-ibritumomab tiuxetan may have potential late effects in some cases of relapsed follicular lymphomas, and we must be careful to start the next treatment after RIT.
• Report on the 44th Annual Meeting of Japan Health Physics Society, HOSONO Makoto, 保健物理 : hoken buturi, 保健物理 : hoken buturi, 46(4), 288 - 291, Dec. 01 2011
• ¹⁸F‐FDG PET/CTにてsuperscanを呈した腎癌骨転移の1例, 兵頭朋子, 石井一成, 細野眞, 阪本祐一, 米矢吉宏, 柳生行伸, 土屋典生, 熊野正士, 足利竜一朗, 中村一郎, 植村天受, 村上卓道, 核医学, 核医学, 48(4), 471 - 471, Nov. 2011
• 核医学治療の有効性と環境整備および今後の展望, 細野眞, 核医学, 核医学, 48(3), 245, Sep. 30 2011
• 高精度放射線治療におけるPET/CTの臨床的有効性に関する検討, 大久保充, 小泉潔, 徳植公一, 西村恭昌, 細野眞, 核医学, 核医学, 48(3), 238, Sep. 30 2011
• The iliac wing sign: An indicator of the presence of bone and/or soft-tissue injury of the pelvis and hips., Kakigi T, Hosono M, Shimono T, Hiraoka T, Nishimura K, European journal of radiology, European journal of radiology, 81(9), 2348 - 2352, Sep. 2011 , Refereed
  DOI
• Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma., Hanaoka K, Hosono M, Usami K, Tatsumi Y, Yamazoe Y, Komeya Y, Tsuchiya N, Ishii K, Sumita M, Nuclear medicine communications, Nuclear medicine communications, 32(8), 678 - 683, Aug. 2011 , Refereed
  DOI
• [Evaluation of patient dose from diagnostic X-ray using glass badges]., Usami K, Sakaguchi K, Ootsuka M, Nagamoto K, Inoue R, Fukuda K, Kano Y, Yoshida K, Hosono M, Nihon Hoshasen Gijutsu Gakkai zasshi, Nihon Hoshasen Gijutsu Gakkai zasshi, 67(7), 785 - 792, Jul. 20 2011 , Refereed
  Summary:Radiography is used in medical practices based on the principles of justification and optimization. Patients’ exposure doses should be kept as low as still allows for image quality that does not disturb the diagnostic processes. To optimize diagnostic radiological procedures, the international commission on radiological protection (ICRP) advocated the establishment of diagnosis reference levels (DRLs) in the new basic recommendation (Publication 103) in 2007 by stating that “The DRL should be expressed as a readily measurable patient-dose-related quantity for the specified procedure.” In th...
  DOI
• 医療放射線の安全確保と有効利用に関する研究「医療放射線の安全確保のための立ち入り検査のあり方に関する研究」, 細野眞, 山口一郎, 小高喜久雄, 矢野和秀, 医療放射線の安全確保と有効利用に関する研究 平成22年度 総括・分担研究報告書, 医療放射線の安全確保と有効利用に関する研究 平成22年度 総括・分担研究報告書, 68 - 90, 2011
• 医療放射線の安全確保と有効利用に関する研究 診療用放射性同位元素使用室への入退出時における患者のスリッパ等の履き替えの必要性に関する検討, 細野眞, 山口一郎, 金谷信一, 小高喜久雄, 渡邉浩, 池渕秀治, 中村伸貴, 柳田幸子, 医療放射線の安全確保と有効利用に関する研究 平成22年度 総括・分担研究報告書, 医療放射線の安全確保と有効利用に関する研究 平成22年度 総括・分担研究報告書, 107 - 114, 2011
• 医療放射線の安全確保と有効利用に関する研究「エックス線診療室等のしゃへい評価法に関する研究」, 細野眞, 山口一郎, 小高喜久雄, 渡邉浩, 堀越亜希子, 池渕秀治, 柳田幸子, 医療放射線の安全確保と有効利用に関する研究 平成22年度 総括・分担研究報告書, 医療放射線の安全確保と有効利用に関する研究 平成22年度 総括・分担研究報告書, 91 - 106, 2011
• Report on the 44th Annual Meeting of Japan Health Physics Society, HOSONO Makoto, Jpn. J. Health Phys., Jpn. J. Health Phys., 46(4), 288 - 291, 2011
• Decreased brain FDG uptake in patients with extensive non-Hodgkin's lymphoma lesions., Hanaoka K, Hosono M, Shimono T, Usami K, Komeya Y, Tsuchiya N, Yamazoe Y, Ishii K, Tatsumi Y, Sumita M, Annals of nuclear medicine, Annals of nuclear medicine, 24(10), 707 - 711, Dec. 2010 , Refereed
  DOI
• FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma., Okada M, Sato N, Ishii K, Matsumura K, Hosono M, Murakami T, Radiographics : a review publication of the Radiological Society of North America, Inc, Radiographics : a review publication of the Radiological Society of North America, Inc, 30(4), 939 - 957, Jul. 2010 , Refereed
  DOI
• Radiation treatment planning using positron emission and computed tomography for lung and pharyngeal cancers: a multiple-threshold method for [(18)F]fluoro-2-deoxyglucose activity., Okubo M, Nishimura Y, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Hanaoka K, Hosono M, International journal of radiation oncology, biology, physics, International journal of radiation oncology, biology, physics, 77(2), 350 - 356, Jun. 2010 , Refereed
  DOI
• 診断参考レベルの国内導入に向けて, 細野眞, 宇佐美公男, 岡野友宏, 米矢吉宏, 土屋典生, 赤羽正章, 成田浩人, 大場久照, 山口一郎, 並木宣雄, 日本医学放射線学会総会抄録集, 日本医学放射線学会総会抄録集, 69th, S146, Feb. 28 2010
• Fourth ventricular mixed germ cell tumor demonstrating adipose tissue in a young adult, KURIU Akihiro, SHIMONO Taro, KUWABARA Masatomo, ASHIKAGA Ryuichiro, HOSONO Makoto, MURAKAMI Takamichi, Jpn J Radiol, Jpn J Radiol, 28(2), 166 - 168, Feb. 2010 , Refereed
  DOI
• Radiation treatment planning using positron emission and computed tomography (PET/CT) for lung and pharyngeal cancers: A multiple thresholds method for FDG activity., Int J Radiat Oncol Biol Phys, Int J Radiat Oncol Biol Phys, 77, 350 - 356, 2010
• 医療放射線の安全確保に関する研究 エックス線診療施設の遮へい評価法に関する調査研究, 細野眞, 大場久照, 三田創吾, 浅沼治, 山口一郎, 小高喜久雄, 池渕秀治, 中村伸貴, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, KADAI6,1-29, 2010
• 医療放射線の安全確保に関する研究「医療機関で行う死亡時画像病理診断(Ai=Autopsy imaging)における放射線防護のためのルール整備に関する研究」, 細野眞, 山口一郎, 金谷信一, 小高喜久雄, 櫻井公一, 池渕秀治, 中村吉秀, 中村伸貴, 柳田幸子, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, KADAI4,1-17, 2010
• 医療放射線の安全確保に関する研究 Positron Emission Mammography(陽電子放出乳房撮影装置)の有用性と使用場所の放射線防護に関する検討, 井上登美夫, 細野眞, 雫石一也, 山口一郎, 池渕秀治, 中村伸貴, 柳田幸子, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, KADAI1,77-84, 2010
• 医療放射線の安全確保に関する研究「診断参考レベルの導入に向けたリスクコミュニケーションのあり方に関する研究」, 細野眞, 山口一郎, 金谷信一, 西澤真理子, 小高喜久雄, 諸澄邦彦, 櫻井公一, 池渕秀治, 中村吉秀, 中村伸貴, 柳田幸子, 医療放射線の安全確保に関する研究 平成19-21年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成19-21年度 総括・分担研究報告書, 23 - 38, 2010
• 医療放射線の安全確保に関する研究「診療用高エネルギー放射線発生装置の運転に伴い発生する放射化物の適正な管理に関する研究」, 細野眞, 山口一郎, 小高喜久雄, 藤淵俊王, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成21年度 総括・分担研究報告書, KADAI4,31-96, 2010
• Worldwide trends in radiation protection in medicine, HOSONO M, Jpn. J. Radiol. Technol., Jpn. J. Radiol. Technol., 54(13), 1772 - 1778, Dec. 2009
• Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions., Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T, Annals of nuclear medicine, Annals of nuclear medicine, 23(4), 349 - 354, Jun. 2009 , Refereed
  DOI
• Ring-shaped lateral ventricular nodules: an incidental finding on brain magnetic resonance imaging., Shimono T, Hosono M, Ashikaga R, Kumano S, Imaoka I, Yagyu Y, Okada M, Kuwabara M, Murakami T, Neuroradiology, Neuroradiology, 51(3), 145 - 150, Mar. 2009 , Refereed
  DOI
• [Research on the shielding evaluation method for medical X-ray imaging facilities]., Ohba H, Fujibuchi T, Mita S, Horikoshi A, Iwanaga T, Ikebuchi H, Hosono M, Nihon Hoshasen Gijutsu Gakkai zasshi, Nihon Hoshasen Gijutsu Gakkai zasshi, 65(1), 57 - 63, Jan. 20 2009 , Refereed
  Summary:The purpose of this study was to verify the shielding evaluation method for medical X-ray imaging facilities in Report No. 147 of the National Council on Radiation Protection and Measurements (NCRP). We investigated the concept of radiation protection and the major revised point in Report No. 147. The goal of radiation protection in Report No. 147 was compared with that in Japan. Using the data of the Imaging Performance Assessment of CT scanners (ImPACT) 2006 and the latest pre-installation manuals of several manufactures for different computed tomography (CT) scanner models, we verified t...
  DOI
• 医療放射線の安全確保に関する研究 放射線診療全般で患者が受ける放射線の量の把握・放射線診療の説明のあり方に関する検討 医療での放射線リスクの説明のあり方に関する研究, 細野眞, 山口一郎, 金谷信一, 西澤真理子, 小高喜久雄, 諸澄邦彦, 櫻井公一, 池渕秀治, 中村吉秀, 中村伸貴, 医療放射線の安全確保に関する研究 平成20年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成20年度 総括・分担研究報告書, 124 - 168, 2009
• 医療放射線の安全確保に関する研究 放射線診療全般で患者が受ける放射線の量の把握・放射線診療の説明のあり方に関する検討 放射性医薬品(医療機器)を投与された患者の退出基準のあり方に関する研究, 細野眞, 山口一郎, 金谷信一, 小高喜久雄, 諸澄邦彦, 櫻井公一, 池渕秀治, 中村吉秀, 中村伸貴, 医療放射線の安全確保に関する研究 平成20年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成20年度 総括・分担研究報告書, 169 - 178, 2009
• 医療放射線の安全確保に関する研究 放射線診療全般で患者が受ける放射線の量の把握・放射線診療の説明のあり方に関する検討 医療で用いたI‐131の汚染物を減衰待ち保管により10半減期後に清掃工場に搬入する場合の清掃作業者や公衆への放射線曝露量の推計, 細野眞, 山口一郎, 金谷信一, 小高喜久雄, 諸澄邦彦, 櫻井公一, 池渕秀治, 中村吉秀, 中村伸貴, 医療放射線の安全確保に関する研究 平成20年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成20年度 総括・分担研究報告書, 179 - 188, 2009
• Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer., Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, Shiozaki H, Annals of nuclear medicine, Annals of nuclear medicine, 23(1), 73 - 80, Jan. 2009 , Refereed
  DOI
• Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system., Okubo M, Nishimura Y, Nakamatsu K, Okumura M, Shibata T, Kanamori S, Hanaoka K, Hosono M, Annals of nuclear medicine, Annals of nuclear medicine, 22(7), 579 - 586, Aug. 2008 , Refereed
  DOI
• "Prominent ear sign" on diffusion-weighted magnetic resonance imaging in relapsing polychondritis., Kuwabara M, Shimono T, Toyomasu M, Shioyama M, Mitsui Y, Yoshinaga E, Kawada A, Hosono M, Murakami T, Kusunoki S, Radiation medicine, Radiation medicine, 26(7), 438 - 441, Aug. 2008 , Refereed
  DOI
• Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas., Yoh T, Hosono M, Komeya Y, Im SW, Ashikaga R, Shimono T, Tsuchiya N, Okada M, Hanada K, Yagyu Y, Nishimura Y, Murakami T, Annals of nuclear medicine, Annals of nuclear medicine, 22(6), 513 - 519, Jul. 2008 , Refereed
  DOI
• Comparison between one-route and two-route injection for liver and aortic enhancement using MDCT., Okada M, Murakami T, Kumano S, Imaoka I, Shimono T, Ashikaga R, Hosono M, AJR. American journal of roentgenology, AJR. American journal of roentgenology, 190(6), 323 - 326, Jun. 2008 , Refereed
  DOI
• Discordance of motion artifacts on magnetic resonance imaging in Creutzfeldt-Jakob disease: comparison of diffusion-weighted and conventional imaging sequences., Shimono T, Tsuboyama T, Kuwabara M, Im SW, Yagyu Y, Imaoka I, Ashikaga R, Hosono M, Murakami T, Radiation medicine, Radiation medicine, 26(3), 151 - 155, Apr. 2008 , Refereed
  DOI
• Recent advances in unsealed radionuclide therapy, 細野 眞, 月刊新医療, 月刊新医療, 35(3), 56 - 59, Mar. 2008
• Clinical Usefulness of [^<18>F] FDG-PET for Diagnosis of Bone and Soft Tissue Tumors : An Analysis Based on Multi-center Questionnaire Survey, KATO Katsuhiko, HOSONO Makoto, ITO Kengo, OKADA Masahiro, KOMEYA Yoshihiro, IM Sung-WOON, TSUCHIDA Norio, TORIZUKA Kanji, RADIOISOTOPES, RADIOISOTOPES, 57(1), 13 - 23, Jan. 15 2008
  Summary:The usefulness of [<SUP>18</SUP>F] FDG-PET for the diagnosis of bone and soft tissue tumors was evaluated using 75 cases(20 kinds of diseases)which were collected from7institutions in Japan by sending out questionnaires. The data of the study patients, who had osteosarcoma, Ewing′s sarcoma(including primitive neuroectodermal tumor), liposarcoma, leiomyosarcoma, Hemangiosarcoma, synovial sarcoma, rhabdomyosarcoma, giant cell tumor, schwannoma, malignant fibrous histiocystoma, chondrosarcoma, alveolar soft part sarcoma, epithelioid sarcoma, endometrial stromal sarcoma, hibernoma, fibrosarcoma, multiple osteochondroma, sacral chordoma, Langerhans cell histiocytosis, and neurofibromatosis, respectively, were analyzed. From the analytical results it was concluded that the usefulness of [<SUP>18</SUP>F] FDG-PET is high for the diagnosis of these tumors.
  DOI
• 医療放射線の安全確保に関する研究 放射線診療全般で患者が受ける放射線の量の把握・放射線診療の説明のあり方に関する研究, 細野眞, 山口一郎, 金谷信一, 西澤真理子, 中沢敦, 迫義知, 池渕秀治, 中村伸貴, 医療放射線の安全確保に関する研究 平成19年度 総括・分担研究報告書, 医療放射線の安全確保に関する研究 平成19年度 総括・分担研究報告書, 406 - 448, 2008
• Clinical usefulness of <18F> FDG-PET for diagnosis of bone and soft tissue tumors: an analysis based on multi-center questionnaire survey, 加藤 克彦, 細野 眞, 伊藤 健吾, Radioisotopes, Radioisotopes, 57(1), 15 - 25, Jan. 2008
  DOI
• [Advancement of the imaging for hepatic malignancies]., Kumano S, Okada M, Imaoka I, Shimono T, Hosono M, Murakami T, Gan to kagaku ryoho. Cancer & chemotherapy, Gan to kagaku ryoho. Cancer & chemotherapy, 34, 1357 - 1360, Sep. 2007 , Refereed
• Contrast enhanced MDCT, 22(5), 106 - 109, 2007
• Regional cerebral blood flow in the assessment of major depression and Alzheimer's disease in the early elderly., Hanada K, Hosono M, Kudo T, Hitomi Y, Yagyu Y, Kirime E, Komeya Y, Tsujii N, Hitomi K, Nishimura Y, Nuclear medicine communications, Nuclear medicine communications, 27(6), 535 - 541, Jun. 2006 , Refereed
  DOI
• 国際放射線防護委員会新勧告における放射線荷重係数等の検討, 細野真, 米矢吉宏, 油野民雄, 日下部きよ子, 草間経二, 山口一郎, 小林一三, 渡辺浩, 並木宣雄, 藤村洋子, 堀越亜希子, 核医学, 核医学, 42(3), 293, Sep. 20 2005
• Radiotherapy and ND-YAG laser for locally advanced non-small cell lung cancer with malignant airwary stenosis and dyspnea, NISHIMURA Keiichiro, TAKAHASHI Takeo, OSADA Hisato, MURATA Osamu, HONDO Mikito, HOSONO Makoto, HONDA Norinari, The Journal of JASTRO, The Journal of JASTRO, 17(2), 97 - 101, Jun. 25 2005
  DOI
• Aggressive multiple lung metastases from intracranial atypical meningioma, Jpn J Tomogrraphy, Jpn J Tomogrraphy, 32(1), 24 - 27, Jan. 2005
• RADIOTHERAPY AND ND-YAG LASER FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER WITH MALIGNANT AIRWAY STENOSIS AND DYSPNEA, NISHIMURA Keiichiro, TAKAHASHI Takeo, OSADA Hisato, MURATA Osamu, HONDO Mikito, HOSONO Makoto, HONDA Norinari, The Journal of JASTRO, The Journal of JASTRO, 17(2), 97 - 101, 2005
  Summary:Locally advanced non-small cell lung cancer is often inoperable. It is difficult to choose the optimal therapy for locally advanced lung carcinoma with malignant airway obstruction. We applied Neodymiumyttrium-aluminum garnet (Nd-YAG) laser therapy combined with external beam radiotherapy. Seven patients were treated with Nd-YAG laser and 60 Gy and more of conventional radiotherapy. All patients had malignant airway obstructions and severe dyspnea at the beginning of Nd-YAG laser therapy. These patients received good to excellent palliation and were able to have normal daily lifes after the treatments. The Nd-YAG laser combined with external radiotherapy may be one of the most useful treatment for locally advanced lung cancer with malignant airway stenosis to improve quality of life.
  DOI
• Extraosseous accumulation of 99mTc-MDP in lymph node metastases of small cell carcinoma of the esophagus, Ann Nucl Med, Ann Nucl Med, 18, 157 - 160, Oct. 2004
• A new bifunctional chelating agent conjugated with monoclonal antibody and labelled with technetium-99m for targeted scintigraphy:6-(4-isothiocyanatobenzyl)-5, 7-dioxo -1, 11- (carboxymethyl)-1, 4, 8, 11 - tetraazacyclotridecane, MISHRA Ak, PANWAR P, HOSONO M, CHUTTANI K, MISHRA P, SHARMA Rk, CHATAL Jf, J Drug Targeting, J Drug Targeting, 12(9-10), 559 - 567, Oct. 2004 , Refereed
  DOI
• Extraosseous accumulation of 99mTc-MDP in lymph node metastases of small cell carcinoma of the esophagus., Takahashi T, Machida K, Honda N, Hosono M, Oku S, Osada H, Murata O, Nishimura K, Ohno H, Annals of nuclear medicine, Annals of nuclear medicine, 18, 157 - 160, Apr. 2004 , Refereed
• [Drawing up the guidelines for ventilation, draining and disposal of radioactive medical waste]., Koizumi M, Endo K, Yokoyama K, Narita Y, Kinoshita F, Hosono M, Kusakabe K, Kosaka N, Mori Y, Kosuda S, Kaku igaku. The Japanese journal of nuclear medicine, Kaku igaku. The Japanese journal of nuclear medicine, 41, 48 - 50, Feb. 2004 , Refereed
• Three-dimensional stereotactic surface projection of brain perfusion SPECT improves diagnosis of Alzheimer's disease., Honda N, Machida K, Matsumoto T, Matsuda H, Imabayashi E, Hashimoto J, Hosono M, Inoue Y, Koizum K, Kosuda S, Momose T, Mori Y, Oshima M, Annals of nuclear medicine, Annals of nuclear medicine, 17, 641 - 648, Dec. 2003 , Refereed
• Optimal Injection Protocol In Hepatic Dynamic CT Using MDCT, 23(9), 1017 - 1025, Sep. 2003
• Distribution of intrasplenically injected colon cancer cells following pneumoperitoneum in mice, Surg Endosc, Surg Endosc, 17(8), 1278 - 1282, Aug. 2003
  DOI
• Visualization of fatal hepatic necrosis on bone scan, HOSONO M, MACHIDA K, HONDA N, TAKAHASHI T, OHTAWA N, Clinical Nuclear Medicine, Clinical Nuclear Medicine, 28(5), 398 - 399, May 2003
  DOI
• Spontaneous regression of chest wall malignant lymphoma presentation on Ga-67 imaging, Clin Nucl Med, Clin Nucl Med, 28(5), 405 - 407, May 2003
  DOI
• Visualization of fatal hepatic necrosis on bone scan., Hosono M, Machida K, Honda N, Takahashi T, Ohtawa N, Clinical nuclear medicine, Clinical nuclear medicine, 28, 398 - 399, May 2003 , Refereed
  DOI
• Spontaneous regression of chest wall malignant lymphoma. Presentation on Ga-67 imaging., Machida K, Inoue Y, Honda N, Hosono M, Takahashi T, Kashimada A, Clinical nuclear medicine, Clinical nuclear medicine, 28, 405 - 407, May 2003 , Refereed
  DOI
• Adult embryonal rhabdomyosarcoma in axilla., Takahashi T, Machida K, Honda N, Hosono M, Kashimada A, Murata O, Osada H, Nishimura K, Radiation medicine, Radiation medicine, 21, 135 - 137, May 2003 , Refereed
• Adult embryonal rhabdomyosarcoma in axilla, Radiation Medicine, Radiation Medicine, 21(3), 135 - 137, Mar. 2003
• Effective radiotherapy and an abscopal effect for bone metastases of an unknown origin, Jpn J Tomogrraphy, Jpn J Tomogrraphy, 30, 96 - 99, Feb. 2003
• Gallium-67 demonstration of extensive soft-tissue involvement of multiple myeloma., Hosono M, Machida K, Inoue Y, Honda N, Takahashi T, Kashimada A, Ohtawa N, Ohno H, Yamano T, Annals of nuclear medicine, Annals of nuclear medicine, 17(1), 69 - 72, Feb. 2003 , Refereed
• Intense gallium-67 accumulation in primary mediastinal pure seminomas, HOSONO M, MACHIDA K, HONDA N, TAKAHASHI T, KASHIMADA A, MURATA O, OSADA H, OHTAWA N, ITOYAMA S, Clinical Nuclear Medicine, Clinical Nuclear Medicine, 28(1), 25 - 28, Jan. 2003
  DOI
• Gallium-67 demonstration of extensive soft-tissue involvement of multiple myeloma, Ann Nucl Med, Ann Nucl Med, 17(1), 69 - 72, Jan. 2003
• Intense Ga-67 accumulation in pure primary mediastinal seminomas., Hosono M, Machida K, Honda N, Takahashi T, Kashimada A, Murata O, Osada H, Ohtawa N, Itoyama S, Clinical nuclear medicine, Clinical nuclear medicine, 28, 25 - 28, Jan. 2003 , Refereed
  DOI
• EVALUATION OF QOL IN CANCER PATIENTS TREATED WITH RADIATION THERAPY, TAKAHASHI Takeo, MACHIDA Kikuo, HONDA Norinari, HOSONO Makoto, MURATA Osamu, OSADA Hisato, OMICHI Masahide, The Journal of JASTRO, The Journal of JASTRO, 14(4), 233 - 238, Dec. 25 2002
  DOI
• Quantitative lung perfusion scintigraphy and detection of intrapulmonary shunt in liver cirrhosis, Ann Nucl Med, Ann Nucl Med, 16(8), 577 - 581, Dec. 2002
• Quantitative lung perfusion scintigraphy and detection of intrapulmonary shunt in liver cirrhosis., Hosono M, Machida K, Honda N, Takahashi T, Kashimada A, Osada H, Murata O, Ohtawa N, Nishimura K, Annals of nuclear medicine, Annals of nuclear medicine, 16, 577 - 581, Dec. 2002 , Refereed
• Interobserver variation in diagnosis of dementia by brain perfusion SPECT., Honda N, Machida K, Hosono M, Matsumoto T, Matsuda H, Oshima M, Koizumi K, Kosuda S, Momose T, Mori Y, Hashimoto J, Shimizu Y, Radiation medicine, Radiation medicine, 20, 281 - 289, Nov. 2002 , Refereed
• Scintigraphic findings of MALT lymphoma of the thyroid., Honda N, Machida K, Inoue Y, Hosono M, Takahashi T, Kashimada A, Osada H, Murata O, Ohmichi M, Watanabe W, Okada T, Itoyama S, Annals of nuclear medicine, Annals of nuclear medicine, 16, 289 - 292, Jun. 2002 , Refereed
• Interobserver variation in diagnosis of dementia by brain perfusion SPECT, Radiation Medicine, Radiation Medicine, 20, 281 - 289, May 2002
• Current topics of nuclear medicine in lung cancer, 本田 憲業, 町田 喜久雄, 細野 眞, 月刊新医療, 月刊新医療, 29(5), 112 - 115, May 2002
• Measurement of decreased cerebellar blood flow of Machado-Joseph Disease by brain perfusion SPECT, Jpn J Tomography, Jpn J Tomography, 28, 94 - 98, Mar. 2002
• Increased insufflation pressure enhances the development of liver metastasis in a mouse laparoscopy model, Surg Endosc, Surg Endosc, 16, 331 - 335, Mar. 2002
  DOI
• Noninvasive quantitative monitoring of cerebral blood flow in aneurysmal subarachnoid hemorrhage with 99mTc-ECD, Nucl Med Comm, Nucl Med Comm, 23, 5 - 11, Jan. 2002
• Increased uptake of Tc-99m MDP in pulmonary osseous chondrosarcoma in a patient with Carney’s syndrome, Jpn J Tomography, Jpn J Tomography, 29, 29 - 32, Jan. 2002
• Evaluation of QOL in cancer patients treated with radiation therapy., TAKAHASHI Takeo, MACHIDA Kikuo, HONDA Norinari, HOSONO Makoto, MURATA Osamu, OSADA Hisato, OMICHI Masahide, J Jpn Soc Ther Radiol Oncol, J Jpn Soc Ther Radiol Oncol, 14(4), 233 - 238, 2002
  Summary:Introduction: Evaluation of QOL in cancer patients is an important theme. However, we do not have an established method to assess QOL in cancer patients during radiotherapy in Japan. We evaluated both the changes of QOL and the factors affecting QOL in radiotherapy patients.<BR>Materials and Methods: Three hundred and fifty-five cancer patients, who filled in a questionnaire at the beginning, middle, and end of radiotherapy between 1998 and 2001, were studied. Weused"The QOL Questionnaire for Cancer Patients Treated with Anticancer Drugs (QOL-ACD)" devisedby Kurihara et al, the Ministry of Health and Welfare. The QOL Questionnaire had five categories: physical activity, physical condition, mental state, social interaction, and face scale. The total score, sum of the score of five categories, were established synthetically (maximum score is 110).<BR>Results: The mean of total QOL scores were 75.8, 77.6, and 78.2 at the beginning, middle, and end of radiotherapy respectively. Patients with symptoms related to cancer had apparent improvement of QOL score. Patients receiving chemotherapy had a decreased QOL score at the end of radiotherapy. The score of physical condition was reduced improvement.<BR>Conclusions: It was suggested that radiotherapy could be performed without losing QOL of cancer patients, including older patients. However, patients receiving chemotherapy and those with head and neck cancer may lose their QOL, therfore, we should treat such patients carefully.
  DOI
• Oligodendroglioma with cystic component in infant, Computerized Medical Imaging and Graphics, Computerized Medical Imaging and Graphics, 25, 361 - 365, Oct. 2001
  DOI
• Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer, Hosono MN, Hosono M, Mishra AK Faivre-Chauvet A Gautherot E Barbet, J, Knapp FF Chatal JF, Ann Nucl Med, Ann Nucl Med, 14, 173 - 179, Jun. 2000 , Refereed
• Clinical Application of 133-Xe Ventilation Scintigraphy, HONDA Norinari, MACHIDA Kikuo, HOSONO Makoto, 日本醫學放射線學會雜誌, 日本醫學放射線學會雜誌, 60(5), 237 - 242, Apr. 25 2000
• Clinical Application of 133-Xe Ventilation Scintigraphy, Honda Norinari, Machida Kikuo, Hosono Makoto, 日本医学放射線学会雑誌, 日本医学放射線学会雑誌, 60(5), 237 - 242, Apr. 25 2000
• Two-step targeting and dosimetry for small-cell lung cancer xenograft with anti-NCAM/anti-histamine bispecific antibody and radioiodinated bivalent hapten, Hosono M, Hosono MN, Kraeber-Bod?r?, F Devys A Thedrez, P Faivre-Chauvet A Gautherot E Barbet, J, Chatal JF, J Nucl Med, J Nucl Med, 40, 1216 - 1221, Oct. 1999 , Refereed
• Cardivascular effects of colforsin daropate hydrochloride, a novel drug for the treatment of acute heart failure, HOSONO Makoto, Folia Pharmacologica Japonica, Folia Pharmacologica Japonica, 114(2), 83 - 88, Aug. 01 1999
  Summary:Colforsin daropate hydrochloride (COL) is a water-soluble forskolin derivative for the treatment of acute heart failure. COL, like forskolin, stimulated adenylate cyclase (AC) directly and produced pharmacologic activities accompanied by the increase in cellular cAMP. COL was different from forskolin in water-solubility, duration of action, BBB permeability, oral activity and AC-subtype selectivity. COL was a inodilator with positive inotropic and vasodilator effects and was effective on a β-receptor desensitized-heart model in which the effects of β-agonists and PDE inhibitors were attenuated. COL improved cardiac function in some heart failure models. In the clinical studies, COL improved hemodynamics, subjective and objective symptoms of heart failure patients, and was also effective in the catecholamine-resistaiit heart failure patients. COL is a first clinically available adenylate cyclase activator. Further information from the post-marketing-surveillance will provide information that will enable more adequate usage of this drug.
  DOI
• Nuclear Oncology with Monoclonal Antibodies and Peptides, HOSONO Makoto, 核医学, 核医学, 35(8), 681 - 687, Oct. 20 1998
• Nuclear Oncology with Monoclonal Antibodies and Peptides, HOSONO Makoto, 核医学, 核医学, 35(8), 681 - 687, Oct. 20 1998
• Nuclear Medicine in Europe, HOSONO Makoto, Radioisotopes, Radioisotopes, 47(6), 531 - 532, Jun. 1998
  DOI
• Localization of colorectal carcinoma by rhenium-188-labeled B72.3 antibody in xenografted mice, Hosono MN, Hosono M, Zamora PO, Guhlke S, Haberberger T, Bender H, Knapp FFR Jr, Biersack HJ, Ann Nucl Med, Ann Nucl Med, 12(2), 83 - 88, Feb. 1998 , Refereed
• Nuclear medicine in Europe. Mainl on France., 細野 眞, RADIOISOTOPES, RADIOISOTOPES, 47(6), 531 - 532, 1998
  DOI
• Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten, Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thedrez P, Fiche M, Gautherot E, Barbet J, Chatal JF, J Nucl Med, J Nucl Med, 39(9), 1608 - 1613, 1998 , Refereed
• Localization of small-cell lung cancer xenografts with I-125-, In-111-, and Re-188-somatostatin analogs, Hosono M, Hosono MN, Haberberger T, Zamora PO, Bender H, Guhlke S, Knapp FFR Jr, Biersack HJ, Cancer Science, Cancer Science, 87, 995 - 1000, 1996 , Refereed
• Effect of circulating antigen on immunoscintigraphy of ovarian cancer patients using anti-CA125 monoclonal antibody, Sakahara H, Hosono M, Kobayashi H, Yao Z, Saga T, Yano S, Endo K, Mori T, Konishi J, Cancer Science, Cancer Science, 87, 655 - 661, 1996 , Refereed
• Immnoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin, Cancer Immunol Immunother, Cancer Immunol Immunother, Cancer Immunol Immunother, 41, 1157 - 1161, 1995 , Refereed
• Diagnostic value of Tc-99m(V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy, Kobayashi H, Kotoura Y, Hosono Mariko, Sakahara H, Hosono M, Yao Z, Ysuboyama T, Yamamuro T, Endo K, Konishi J, Clinical Nuclear Medicine, Clinical Nuclear Medicine, 20, 361 - 364, 1995 , Refereed
• Radioimmunodetection of human leukemia with anti-interleukin-2 receptor antibody in severe combined immunodeficiency mice, Hosono M, Takaori-Kondo A, Yao Z, Kobayashi H, Hosono MN, Sakahara H, Imada K, Okuma M, Uchiyama T, Konishi J, Nuclear Medicine and Biology, Nuclear Medicine and Biology, 22, 869 - 874, 1995 , Refereed
  DOI
• Detection of homing, proliferation, and infiltration sites of adult T cell leukemia cells in severe combined immunodeficiency mice using radiometric techniques, Takaori-Kondo A, Hosono M, Imada K, Yao Z, Sakahara H, Yamabe H, Konishi J, Okuma M, Uchiyama K, Cancer Science, Cancer Science, 86, 322 - 328, 1995 , Refereed
• Comparison of the chase effects of avidin, streptavidin, neutravidin, and avidin-ferritin on a radiolabeled biotinylated anti-tumor monoclonal antibody, Kobayashi H, Sakahara H, Endo K, Hosono M, Yao Z, Toyama S, Konishi J, Cancer Science, Cancer Science, 86, 310 - 314, 1995 , Refereed
• Kinetics of platelets in dogs with thrombocytopenia induced by antiglycoprotein IIb/IIIa receptor monoclonal antibody, Hosono M, Sone N, Endo K, Saga T, Kobayashi H, Hosono MN, Sakahara H, Yasunaga K, Konishi J, Nuclear Medicine and Biology, Nuclear Medicine and Biology, 22, 71 - 76, 1995 , Refereed
  DOI
• Case report: Uptake of pentavalent technetium-99m dimercaptosuccunic acid by pigmented villonodular synovitis: comparison with computed tomography, magnetic resonance imaging and gallium-67 scintigraphy, Kobayashi H, Kotoura Y, Hosono M, Sakahara H, Yamamuro T, Endo K, Konishi J, Br J Radiology, Br J Radiology, 67, 1030 - 1032, 1994 , Refereed
• Improved clearance of radiolabeled biotinylated monoclonal antibody following the infusion of avidin as "chase" without decreased accumulation in the target tumor, Kobayashi H, Sakahara H, Hosono M, Yao Z, Toyama S, Endo K, Konishi J, J Nucl Med, J Nucl Med, 35, 1677 - 1684, 1994 , Refereed
• Initial studies on Tc-99m- and Re-188-somatostatin analogues: stannous-mediated direct-labeling and biodistribution in normal mice, Haberberger T, Zamora P, Hosono M, Hosono MN, Bender H, Guhlke S, Knapp FFR, Biersask HJ, Technetium and Rhenium chemistry and nuclear medicine, Technetium and Rhenium chemistry and nuclear medicine, 1994 , Refereed
• Intraosseous hemangiomatosis: technetium-99m-(V)-dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging, Kobayashi H, Shigeno C, Sakahara H, Hosono Mariko, Hosono M, Yao Z, Endo K, Konishi J, J Nucl Med, J Nucl Med, 35, 1482 - 1484, 1994 , Refereed
• Scintigraphic detection of neural-cell-derived small-cell lung cancer using glioma-specific antibody, Kobayashi H, Sakahara H, Hosono M, Shirato M, Kondo S, Miyatake S, Kikuchi H, Namba Y, Endo K, Konishi J, J Cancer Res Clin Oncol, J Cancer Res Clin Oncol, 120, 259 - 262, 1994 , Refereed
• Schwannoma of the extremities: comparison of MRI and pentavalent technetium-99m-dimercaptosuccinic acid and gallium-67-citrate scintigraphy, Kobayashi H, Kotoura Y, Sakahara H, Hosono Mariko, Hosono M, Tsaboyama T, Yamamuro T, Endo K, Konishi J, J Nucl Med, J Nucl Med, 35, 1174 - 1178, 1994 , Refereed
• Dissociation in serum CA125 concentrations measured by different monoclonal antibodies, Sakahara H, Kousaka T, Hattori N, Tomida K, Yao Z, Hosono M, Kobayashi H, Shirato M, Endo K, Konishi J, Gynecologic Oncology, Gynecologic Oncology, 52, 301 - 305, 1994 , Refereed
• Effect of hyperthermia on tumor uptake of radiolabeled anti-neural cell adhesion molecule antibody in small cell lung cancer xenografts, Hosono MN, Hosono M, Endo K, Ueda R, Onoyama Y, J Nucl Med, J Nucl Med, 35, 504 - 509, 1994 , Refereed
• Treatment of small cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecule monoclonal antibody and evaluation of absorbed dose in tissue, Hosono M, Endo K, Hosono MN, Kobayashi H, Shirato M, Sakahara H, Ueda R, Konishi J, J Nucl Med, J Nucl Med, 35, 296 - 300, 1994 , Refereed
• Soft-tissue tumors: diagnosis with Tc-99m(V) dimiercaptosuccinic acid scintigraphy, Kobayashi H, Sakahara H, Hosono M, Shirato M, Endo K, Kotoura Y, Yamamuro T, Konishi J, Radiology, Radiology, 190, 277 - 280, 1994 , Refereed
• Pentavalent technetium-99m dimercaptosuccinic acid SPECT of metastatic renal cell carcinoma in the scalp and in the brain, Kobayashi H, Sakahara H, Hosono M, Shirato M, Konishi J, Clin Nucl Med, Clin Nucl Med, 19, 136 - 137, 1994 , Refereed
• Scintigraphic detection of xenographted tumors producing human basic fibroblastic growth factor, Kobayashi H, Sakahara H, Hosono M, Shirato M, Konishi J, Takahashi JA, Oda A, Kikuchi H, Endo K, Kozai Y, Cancer Immunology Immunotherapy, Cancer Immunology Immunotherapy, 37, 281 - 285, 1993 , Refereed
• Scintigraphic evaluation of tenosynovial giant cell tumor using technetium-99m(V)-dimercaptosuccinic acid, Kobayashi H, Sakahara H, Hosono M, Shirato M, Konishi J, Kotoura Y, Yamamuro T, Endo K, J Nucl Med, J Nucl Med, 34, 1745 - 1747, 1993 , Refereed
• Changes in CA125 release and surface expression caused by drugs in uterine cervix adenocarcinoma cells, Nakai T, Sakahara H, Endo K, Shirato M, Kobayashi H, Hosono M, Saga T, Sakamoto M, Konishi J, Annals of Nuclear Medicine, Annals of Nuclear Medicine, 7, 133 - 139, 1993 , Refereed
• Similarity and co-expression of tumour-associated antigens recognized by different monoclonal antibodies, Sakahara H, Saga T, Endo K, Kousaka T, Hosono M, Kobayashi H, Shirato M, Konishi J, Br J Cancer, Br J Cancer, 68, 920 - 925, 1993 , Refereed
• In vivo instability of reduction-mediated 99mTc-labeled monoclonal antibody, Sakahara H, Saga T, Endo T, Hattori N, Hosono M, Kobayashi H, Shirato M, Yamamuro T, Toyama S, Arano Y, Yokoyama A, Konishi J, Nucl Med Biol, Nucl Med Biol, 20, 617 - 623, 1993 , Refereed
• Technetium-99m(V) dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein, Kobayashi H, Sakahara H, Itoh T, Kudoh T, Takagi T, Shibuya K, Nomura S, Hosono M, Endo K, Konishi J, J Nucl Med, J Nucl Med, 34, 815 - 817, 1993 , Refereed
• A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer, Kobayashi H, Sakahara H, Saga T, Hosono M, Shirato M, Kanda H, Ishibashi K, Watanabe T, Endo K, Ishiwata I, Konishi J, Cancer Immunol Immunother, Cancer Immunol Immunother, 37, 143 - 149, 1993 , Refereed
• Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients, Hosono M, Saga T, Sakahara H, Kobayashi H, Shirato M, Endo K, Yamamoto T, Akiyama T, Toyoshima K, Konishi J, Cancer Science, Cancer Science, 84, 147 - 152, 1993 , Refereed
• Effect of drugs on malignant cells studied by 1H MRS., 伊島理枝子, 赤坂一之, 中井敏晴, 遠藤啓吾, 細野真, 佐賀恒夫, 阪原晴海, 小西淳二, NMR討論会講演要旨集, NMR討論会講演要旨集, 30th, 341 - 342, Oct. 1991
• Fundamental and clinical studies of the measurement of serum CA 19-9 concentrations in patients with pancreatic and gastrointestinal cancer using (Ball CA 19-9 kits)., HOSONO MAKOTO, ENDO KEIGO, NAKAJIMA KOTOKO, NAKAI TOSHIHARU, SAGA TSUNEO, SAKAHARA HARUMI, KONISHI JUNJI, MANABE TADAO, TOBE RYUKICHI, 月刊医学と薬学, 月刊医学と薬学, 25(1), 117 - 123, Jan. 1991
• Drug effects on CA125 antigen expression and antibody binding to cancer cells, Nakai T, Endo K, Hosono M, Saga T, Watanabe Y, Sakahara H, Imai K, Yachi A, Kiyozuka Y, Ishiwata I, Konishi J, Int J Cancer, Int J Cancer, 48, 463 - 467, 1991 , Refereed
  DOI
• Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody, Saga T, Endo K, Akiyama T, Sakahara H, Koizumi M, Watanabe Y, Nakai T, Hosono M, Yamamoto T, Toyoshima K, Konishi J, Cancer Res, Cancer Res, 51, 990 - 994, 1991 , Refereed
• Antigenic nature in a care who showed remarkably high serum CA 125 and normal CA 130 levels., 23(6), 1287 - 1292, Jun. 1990
• Basic and clinical studies on ELSA CA 72-4 kit for measurement of serum CA 72-4 concentrations: Usefulness in patients with gastrointestinal cancer., NAKAI TOSHIHARU, ENDO KEIGO, NAKAJIMA KOTOKO, HATTORI NORIKO, HOSONO MAKOTO, SAGA TSUNEO, WATANABE YUJI, SAKAHARA HARUMI, TOBE RYUKICHI, 核医学, 核医学, 27(5), 505 - 511, May 1990
• Basic and clinical studies on SPan-1 RIABEAD kit: Usefulness in patients wiith pancreatic and biliary tract cancer., 26(12), 1559 - 1565, Dec. 1989
• CT manifestations of a ruptured hepatic tumor after transcatheter arterial embolization, Nagata Y, Kohno S, Saga T, Okajima K, Hosono M, Tamaki M, Kanata T, Takabayashi A, Matsuda S, CT manifestations of a ruptured hepatic tumor after transcatheter arterial embolization, CT manifestations of a ruptured hepatic tumor after transcatheter arterial embolization, 13, 419 - 422, 1989 , Refereed
• Transcatheter Arterial Embolization for Osseous Metastasis of Hepatocellular Carcinoma, Nagata Yasushi, Nakano Yoshihisa, Takahashi Masaji, Abe Mitsuyuki, Saga Tsuneo, Okajima Kaoru, Hosono Makoto, Kohno Shigene, 日本医学放射線学会雑誌, 日本医学放射線学会雑誌, 48(4), 417 - 422, Apr. 25 1988

Books etc

• Health and labor science research grant aid research fiscal year 2016-2018 Research on medical radiation protection corresponding to new treatment method general research report, HOSONO Makoto, YAMAGUCHI Ichiro, TAKAHASHI Takeo, AKAHANE Masaaki, 共著,   2019 03
• Health and Labor Science Research Grants Subsidy Research 2018 "Research on medical radiation protection corresponding to new treatment methods general research report, HOSONO Makoto, YAMAGUCHI Ichiro, TAKAHASHI Takeo, AKAHANE Masaaki, 共著,   2019 03
• Heterogeneity of intratumoral antibody distribution, HANAOKA Kohei, HOSONO Makoto, 共著, Springer International Publishing,   2018 04 , 9783319782379
• Features of ibritumomab as radionuclide therapy. Resistance to ibritumomab in lymphoma, HOSONO Makoto, 共著, Resistance to ibritumomab in lymphoma, Springer International Publishing,   2018 04 , 9783319782386
• Gamut of FDG-PET, HOSONO Makoto, 共著, JSNM,   2012 10
• Safety and Efficient Use of Radiation in Medicine, HOSONO Makoto, 共著, Comprehensive Report,   2012 03
• Comparison of functions of CT, MRI, and PET, 共著,   2005 10

Conference Activities & Talks

• Present status and revision works of DRLs, HOSONO Makoto, 55th Autumn Meeting of Japan Radiological Society,   2019 10 20 , 招待有り, TOYAMA Hiroshi
• Recent updates on radionuclide therapy -focusing on Ra-223-, HOSONO Makoto, 19th Kinki Radiology Forum,   2019 10 05 , 招待有り
• Basics of radiation therapy, HOSONO Makoto, 84th Annual Meeting of Eastern Section of Japanese Urological Association,   2019 10 03 , 招待有り, ASANO Tomohiko
• Outline of research on radiation protection in medicine for novel therapeutic procedures by grant of MHLW for fiscal years 2016-2018, HOSONO Makoto, TAKAHASHI Takeo, YAMAGUCH Ichiro, AKAHANE Masaaki, IKEBUCHI Hideharu, YANAGIDA Sachiko, NAKAMURA Yoshihide, 36th Meeting of Japanese Society of Hyperthermia,   2019 09 07 , TAKAHASHI Takeo
• Trends in safe utilization of medical radiation, HOSONO Makoto, 37th Meeting of Southern Osaka Imaging Study Consortium,   2019 08 28 , 招待有り
• Optimization of respiratory gated 18F-FDG PET/CT scan protocol for cardiac sarcoidosis, Hanaoka K, Watanabe S, Kaida H, Hosono M, Ishii K, Annual Meeting of Society of Nuclear Medicine Molecular Imaging,   2019 06 22 , Society of Nuclear Medicine Molecular Imaging
• Comparison among 18F-FDG uptake parameters for assessing the prognosis of esophageal squamous cell carcinoma, Kaida H, Shiraishi O, Iwama M, Kimura Y, Kitajima K, Hosono M, Yasuda T, Ishii K, Annual Meeting of Society of Nuclear Medicine Molecular Imaging,   2019 06 22 , Society of Nuclear Medicine Molecular Imaging
• Evaluation of respiratory motion-corrected PET/CT in oncological patients, Otani T, Hosono M, Nakamoto Y, Kidera K, Kitaguchi K, Watanabe M, Miyake K, Annual Meeting of Society of Nuclear Medicine Molecular Imaging,   2019 06 22 , Society of Nuclear Medicine Molecular Imaging
• Examination of actual radiation exposure dose of the patients who performed EUS-guided dranage (EUS-BD/EUS-PD/EUS-CD), Takenaka M, Hayashi S, Nishida T, Hosono M, Yoshikawa T, Ishikawa Rei, Okamoto A, Yamazaki T, Nakai A, Omoto S, Minaga K, Kamata K, Yamao K, Kudo M, DDW 2019,   2019 05 18 , DDW 2019
• Radiation protection standards in novel radionuclide therapy, HOSONO Makoto, The 13th Asia Oceania Congress of Nuclear Medicine and Biology,   2019 05 10 , 招待有り, Asia Oceania Federation of Nuclear Medicine and Biology
• Guidelines in radionuclide therapy, HOSONO Makoto, 19th Spring Meeting of Japanese Society of Nuclear Medicine,   2019 04 28
• Perspectives on radionuclide therapy, HOSONO Makoto, 19th Spring Meeting of Japanese Society of Nuclear Medicine,   2019 04 27 , 招待有り
• ICRP perspectives for individualized radionuclide therapy, HOSONO Makoto, Theranostics World Congress 2019 (TWC2019),   2019 03 02 , 招待有り
• Radiation protection for patients and practitioner in fluoroscopy-guided procedures, HOSONO Makoto, 9th Meeting of FIGHT-Japan,   2019 02 24 , 招待有り
• Contribution to PET and RNT as Pharmacist, ASAMI Keita, HOSONO Makoto, Japanese Society of Hospital Pharmacists,   2019 01 20 , 招待有り
• ICRP C3, HOSONO Makoto, Radiation Effect Association,   2018 12 26 , 招待有り
• Management of radiation control in short-lived radionuclides including alpha emitters, HOSONO Makoto, Japanese Society of Radiation Safety Management,   2018 12 06 , 招待有り
• Nuclear Medicine in Oncology, HOSONO Makoto, 62nd Meeting of Fukuoka RI Conference,   2018 10 27 , 招待有り, Fukuoka RI Conference
• Domestic Situations of Nuclear Medicine Therapy and Future Prospects, HOSONO Makoto, 56th Annual Meeting of Japanese Society of Clinical Oncology,   2018 10 19 , 招待有り, Japanese Society of Clinical Oncology
• Radionuclide Therapy, HOSONO Makoto, 31st Annual Meeting of Japanese Society of Radiation Oncology,   2018 10 11 , 招待有り, Japanese Society of Radiation Oncology
• Interpretation and determination of images, HOSONO Makoto, 36th Safety handling course of radioimmunotherapy using Yttrium-90 labeled anti-CD20 antibody,   2018 09 29 , 招待有り
• Significance and application of diagnostic reference levels in ICRP recommendation (Explanation of Pub.135), HOSONO Makoto, Course held by Radiation Effect Association (ICRP Seminar),   2018 09 26 , 招待有り
• Medical use and reasonable safety management of radionuclides (including alpha emitting radionuclides), HOSONO Makoto, 平成30年度秋期放射線安全管理研修会 放射線障害防止中央協議会,   2018 09 20 , 招待有り
• Radiological Protection for Innovative Targeted Therapy, HOSONO Makoto, Annual Meeting of Society of Nuclear Medicine and Molecular Imaging 2018,   2018 06 26 , 招待有り, Society of Nuclear Medicine and Molecular Imaging
• Effectiveness of targeted alpha therapy, HOSONO Makoto, 14th Workshop on safety handling of Ra-223,   2018 05 26 , 招待有り
• Guidelines in radionuclide therapy, HOSONO Makoto, !8th Spring Meeting of JSNM,   2018 05 13 , 招待有り
• From Molecular Imaging to Molecular Radiotherapy, HOSONO Makoto, 18th Spring Meeting of JSNM,   2018 05 12 , 招待有り
• Perspectives of radionuclide therapy, HOSONO Makoto, 18th Spring Meeting of JSNM,   2018 05 12 , 招待有り
• Individualized treatment planning in radionuclide therapy, HOSONO Makoto, 12th Congress of the World Federation of Nuclear Medicine and Biology,   2018 04 20 , 招待有り, 12nd Congress of the World Federation of Nuclear Medicine and Biology
• Radiation Protection in Therapy with Radiopharmaceuticals, HOSONO Makoto, International Workshop on the Biological Effects on Radiation 2018,   2018 03 21 , 招待有り
• Development and clinical application of targeted alpha therapy, HOSONO Makoto, Seminar at ARRONAX,   2018 01 15 , 招待有り, ARRONAX, Nantes University
• Impact of new technology on patient radiation protection in nuclear medicine-including hybrid systems, low dose PET, HOSONO Makoto, International Conference on Radiation Protection in Medicine: Achieving Change in Practice,   2017 12 13 , 招待有り, IAEA
• Efficacy of Targeted Alpha Therapy, HOSONO Makoto,   2017 11 25 , 招待有り, Japan Radioisotope Association
• Targeted Alpha Therapy in Japan, HOSONO Makoto, Seminar at Salgrenska Hospital, University Göteborg,   2017 11 08 , 招待有り, Salgrenska Hospital, University Göteborg
• Current Status on Radionuclide Therapy, HOSONO Makoto, Joint FMU-ICRP Workshop on Radiological Protection in Medicine,   2017 10 03 , 招待有り, Fukushima Medical University and ICRP
• Prognostic impact of 18F-FDG PET parameters and molecular markers expression in resected non-small cell lung cancer patients, HOSONO Makoto, Kaida H, Azuma K, Kawahara A, Sadashima E, Hattori S, Akiba J, Rominger A, Takamori A, Fujimoto K, Hosono M, Ishii K, Murakami T, Ishibashi M,   2017 06 10
• Clinical evaluation and optimization of Q.Clear; a new PET reconstruction algorithm, Otani T, Hosono M, Kanagaki M, Fukumoto G, Onishi Y, Matsubara N, Kimura H, Annual Meeting of Society of Nuclear Medicine and Molecular Imaging,   2017 06 10
• Methods of survey and decontamination of radium-223 dichloride for radionuclide therapy in clinical facilities, Hosono M, Hohara S, Inagaki M, Sakaguchi K, Yoshida S, Yamanishi H, Wakabayashi G, Matsuda T, Ito T, 10th International Symposium on Targeted Alpha Therapy,   2017 05 30
• α線内用療法の有効性（臨床応用に関する基礎的事項）, HOSONO Makoto,   2017 05 27 , 招待有り
• 4D-CTを用いた呼吸同期撮像法の有用性, 藤井 康司, 白髭 賢也, 竹中 達明, 細野 眞, 日本放射線技術学会総会学術大会予稿集,   2017 03
• アルファ線核種の臨床利用における法令と指針, 細野 眞, 日本放射線技術学会総会学術大会予稿集,   2017 03
• FDG-PET/CTで集積を認めた異所性甲状腺癌の一例, 甲斐田 勇人, 石井 一成, 細川 知紗, 仁 誠雲, 細野 眞, 村上 卓道, 花岡 宏平, 乾 浩己, 核医学,   2017 02 , (一社)日本核医学会
• センチネルリンパ節SPECT/CTで肺野に集積を認めた1例, 小西達郎, 坂口健太, 細野眞, 核医学症例検討会症例集,   2017 02
• 甲状腺乳頭癌術後のフォローのPET/CTにて皮膚に多発集積を認めた1例, 尾谷知亮, 細野眞, 金柿光憲, 乘本周平, 木村弘之, 核医学症例検討会症例集,   2017 02
• 上顎洞術後変化としての眼窩下管拡大, 福井 秀行, 柏木 伸夫, 任 誠雲, 甲斐田 勇人, 柳生 行伸, 小塚 健倫, 細川 知紗, 熊野 正士, 鶴崎 正勝, 松木 充, 今岡 いずみ, 石井 一成, 細野 眞, 村上 卓道, Japanese Journal of Radiology,   2017 02
• PET/CTにおける新しい再構成法Q.Clearの検討, 尾谷 知亮, 金柿 光憲, 乗本 周平, 木村 弘之, 細野 眞, Japanese Journal of Radiology,   2017 02
• 前立腺小線源療法後1年以内死亡の3例, 横川 正樹, 中松 清志, 稲田 正浩, 福田 浩平, 建部 仁志, 石川 一樹, 立花 和泉, 門前 一, 金森 修一, 西村 恭昌, 細野 眞, Japanese Journal of Radiology,   2017 02
• Survey on radionuclide therapy facilities in Japan with grants by Ministry of Health, Labour, and Welfare, Hosono M, Ikebuchi H, Nakamura Y, Nakamura N, Yanagida S, Kitaoka A, Annual Congress of European Association of Nuclear Medicine,   2016 10 15
• Estimation of administered fluorodeoxyglucose activity in patients on the basis of dose equivalent rate on head by multiple regression analysis, Hosono M, Sakaguchi K, Imamura T, Takahara N, Hayashi M, Hosokawa C, Yamada M, Ishii K, Annual Congress of European Association of Nuclear Medicine,   2016 10 15
• Survey and decontamination of radium-223 dichloride for alpha- particle radionuclide therapy in clinical facilities, Hosono M, Hohara S, Inagaki M, Yamanishi H, Wakabayashi G, Matsuda T, Sakaguchi K, Hanaoka K, Ito T, Annual Congress of European Association of Nuclear Medicine,   2016 10 15
• 認知症患者における線条体アミロイド沈着の検討, 細川 知紗, 石井 一成, Sauerbeck Julia, Sheiwein Franziska, 甲斐田 勇人, 兵頭 朋子, 山田 穣, 細野 眞, 花岡 宏平, 村上 卓道, 核医学,   2016 10 , (一社)日本核医学会
• 前立腺 前立腺がん診療の新技術 骨転移のある日本人の症候性去勢抵抗性前立腺癌患者への塩化ラジウム-223の第II相試験, 永森 聡, 上村 博司, 和久本 芳彰, 植村 天受, 木村 剛, 横溝 晃, 菊川 浩明, 絹谷 清剛, 細野 眞, 山口 郁, 筒井 弘一, 松永 瑛典, 松原 伸晃, 日本癌治療学会学術集会抄録集,   2016 10
• Pretherapeutic FDG heterogeneity in tumors can predict local control in oropharyngeal cancer patients undergoing intensity-modulated radiation therapy, Hanaoka K, Hosono M, Tatebe H, Ishikawa K, Monzen H, Ishii K, Nishimura Y, Annual Meeting of Society of Nuclear Medicine Molecular Imaging,   2016 06 11
• Texture analysis for FMISO PET/CT in oncology patients receiving extra-beam radiation therapy, Hosono M, Tachibana I, Nishimura Y, Hanaoka K, Sakaguchi K, Ishikawa K, Nakamatsu K, Kanamori S, Annual Meeting of Society of Nuclear Medicine and Molecular Imaging,   2016 06 11
• JSNM Education, Accreditation, and Multidisciplinary Team Practice, HOSONO Makoto, Annual Meeting of Society of Nuclear Medicine,   2016 06 11 , 招待有り
• Dose evaluation and control for Nuclear Medicine. Joint Symposium 2: Dose evaluation and control for medical radiation exposure, HOSONO Makoto, Japan Radiology Congress,   2016 04 14 , 招待有り
• Clinical evaluation and optimization of a new PET reconstruction algorithm Q.Clear in lung cancer, Otani T, Hosono M, Kanagaki M, Fukumoto G, Onishi Y, Matsubara N, Kimura H, ECR 2017,   2016 02 28
• 11C-PiB PET陽性認知症の線条体集積の検討, 細川 知紗, 石井 一成, Sauerbeck Julia, Scheiwein Franziska, 甲斐田 勇人, 山田 穣, 兵頭 朋子, 細野 眞, 花岡 宏平, 村上 卓道, 核医学,   2016 02 , (一社)日本核医学会
• ゼヴァリン療法におけるIn‐111抗体とFDGの腫瘍内不均一性解析, 花岡宏平, 細野眞, 核医学(Web),   2016
• 認知症患者における線条体アミロイド沈着の検討, 細川知紗, 石井一成, SAUERBECK Julia, SHEIWEIN Franziska, 甲斐田勇人, 兵頭朋子, 山田穣, 細野眞, 花岡宏平, 村上卓道, 核医学(Web),   2016
• α核種による治療の現状と将来, HOSONO Makoto, 第132回関西Cancer Therapistの会,   2015 12 02 , 招待有り
• Tumor hypoxia detected by 18F-misonidazole (F-MISO) PET/CT as a prediction of initial tumor response of radiation therapy (RT), Tachibana I, Hosono M, Inada M, Fukuda K, Tatebe H, Ishikawa K, Yokokawa M, Nakamatsu K, Kanamori S, Nishimura Y, ASTRO 2015, 57th annual meeting,   2015 10 18
• Occupational radiation exposure of nursing staff in PET facility in association with performance status of patients, Hosono M, Takahara N, Yakushiji Y, Sakaguchi K, Yamada Y, Hosokawa C, Ishii K, Annual Congress of European Association of Nuclear Medicine,   2015 10 10
• Therapy planning and dose prescription in radioiodine-131 therapy for hyperthyroidism using radioiodine-123 SPECT/CT imaging, Hanaoka K, Hosono M, Otsuka M, Asai Y, Okumura M, Ishii K, Murakami T, Annual Congress of European Association of Nuclear Medicine,   2015 10 10
• Texture analysis for tumor hypoxia visualized by FMISO PET/CT during radiation therapy, Hosono M, Tachibana I, Nishimura Y, Hanaoka K, Kanamori S, Nakamatsu K, Ishikawa K, Sakaguchi K, Annual Congress of European Association of Nuclear Medicine,   2015 10 10
• Assessment of heart injury induced by radiation therapy for esophageal cancer using FDG-PET/CT, Hanaoka k, Hosono M, Inada M, Sakaguchi K, Shimomura K, Tamura M, Matsumoto K, Monzen H, Nishimura Y, Annual Congress of European Association of Nuclear Medicine,   2015 10 10
• Radiation exposure of nursing staff in PET practices in correlation to performance status of patients, Hosono M, Takahara N, Yakushiji Y, Sakaguchi K, Ishii K, SNMMI 2015 Annual Meeting,   2015 06 06
• Updates and Prospects of Alpha-emitters in Targeted Radionuclide Therapy, HOSONO Makoto, 15th International Conference of Radiation Research,   2015 05 25 , 招待有り
• Predictive values of 111In-ibritumomab tiuxetan SPECT/CT and 18F-FDG PET/CT in radioimmunotherapy for B-cell non-Hodgkin's lymphoma, Hanaoka K, Hosono M, Ishii K, Sakaguchi K, Tatsumi Y, Nishimura Y, 15th International Conference of Radiation Research,   2015 05 25
• Tumor hypoxia imaging with 18F-misonidazole (F-MISO) positron emission tomography (PET) during radiation therapy (RT), Tachibana I, Hosono M, Ishikawa K, Nakamatsu K, Matsuura T, Tatebe H, Inada M, Fukuda K, Kanamori S, Nishimura Y, International Conference of Radiation Research,   2015 05 25
• Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition, Ishii K, Hosokawa C, Hyodo T, Wakabayashi Y, Yamada M, Kozuka T, Hosono M, Murakami T, Annual Congress of European Association of Nuclear Medicine,   2014 10 18
• Texture analysis of intratumoral hypoxia on FMISO PET/CT in radiation therapy, Hosono M, Tachibana I, Nishimura Y, Hanaoka K, Kanamori S, Nakamatsu K, Ishikawa K, Annual Congress of European Association of Nuclear Medicine,   2014 10 18
• Predictive value of heterogeneity of intratumoral In-111-Zevalin and FDG distributions for tumor response in Zevalin therapy, Hosono M, Hanaoka K, Ishii K, Sakaguchi K, Yamada M, Komeya Y, Tsuchiya N, Im SW, Tatsumi Y, Matsumura I, Annual Congress of European Association of Nuclear Medicine,   2014 10 18
• Measurement and parameters of α-emitting radium-223 for radionuclide therapy in accordance with radiation protection standards, Hosono M, Hohara S, Yamanishi H, Inagaki M, Wakabayashi G, Matsuda T, Sakaguchi K, Hanaoka K, Itoh T, Annual Congress of European Association of Nuclear Medicine,   2014 10 18
• Heterogeneity of intratumoral hypoxia on FMISO PET/CT in association with local control in radiation therapy, Hosono M, Tachibana I, Nishimura Y, Hanaoka K, Kanamori S, Nakamatsu K, Shibata T, Ishikawa K, Tamura M, ASTRO 2014, 56th annual meeting,   2014 09 14
• Comparison between SUV and BP images acquired using 11C-PIB PET: Questionable PIB accumulation in SUV images, Hosokawa C, Ishii K, Kimura Y, Sakaguchi K, Hosono M, Murakami T, SNMMI 2014 Annual Meeting,   2014 06 07
• Heterogeneity of intratumoral In-111-Zevalin and FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell lymphoma, Hosono M, Hanaoka K, Ishii K, Sakaguchi K, Im SW, Tsuchiya N, Yoshihiro K, Tatsumi Y, Matsumura I, SNMMI 2014 Annual Meeting,   2014 06 07
• Measurement and radiation control of α-emitting radium-223 in radionuclide therapy for prostate cancer with bone metastases, Hosono M, Hohara S, Yamanishi H, Inagaki M, Wakabayashi G, Sakaguchi K, Hanaoka K, Itoh T, SNMMI 2014 Annual Meeting,   2014 06 07
• Present status and future of radionuclide therapy, HOSONO Makoto, Applied physics meeting,   2013 12 14 , 招待有り
• Therapy planning and dose prescription in radioiodine therapy for hyperthyroidism using SPECT/CT, Hosono M, Hanaoka K, Ishii K, Im S, Sakaguchi K, Yagyu Y, Matsukubo Y, Ohno Y, Ikegami H, Annual Congress of European Association of Nuclear Medicine,   2013 10 19
• Association among heterogeneity of intratumoral anti-CD20 antibody distribution, glucose metabolism and therapeutic response in radioimmunotherapy for B-cell lymphoma, Hosono M, Hanaoka K, Ishii K, Im S, Sakaguchi K, Yagyu Y, Komeya Y, Tsuchiya N, Tatsumi Y, Matsumura I, Annual Congress of European Association of Nuclear Medicine,   2013 10 19
• Application of NM imaging to radiation therapy, HOSONO Makoto, Tokai nuclear medicine meeting,   2013 09 28 , 招待有り
• Present status and future of radionuclide therapy, HOSONO Makoto, Imaging meeting of South Osaka,   2013 08 21 , 招待有り
• PET ans Radiation Safety, HOSONO Makoto, PET and nuclear medicine nurse seminar,   2013 06 22 , 招待有り
• Therapy planning and dose prescription in radioiodine therapy for hyperthyroidism using SPECT/CT, Therapy planning, dose prescription in, radioiodine therapy for hyperthyroidism using, SPECT/CT, SNMMI 2013 Annual Meeting,   2013 06 08
• Heterogeneity of CD20 antigen expression and glucose metabolism in correlation with therapeutic response in radioimmunotherapy for B-cell lymphoma, Hosono M, Hanaoka K, Ishii K, Im SW, Sakaguchi K, Yagyu Y, Komeya Y, Tsuchiya N, Tatsumi Y, Matsumura I,   2013 06 08
• Guidelines in nuclear medicine, HOSONO Makoto, JSNM Spring Meeting,   2013 04 28 , 招待有り
• Review on radionuclide therapy, HOSONO Makoto, JSNM Spring Meeting,   2013 04 27 , 招待有り
• Overview of Radiation Protection in Radionuclide Therapy, HOSONO Makoto, international conference on radiation protection in medicine - setting the scene for the next decade,   2012 12
• Radiation Protection in PET/CT, HOSONO Makoto, international conference on radiation protection in medicine - setting the scene for the next decade,   2012 12 , 招待有り
• Three dimensional planning of radioiodine therapy for hyperthyroidism by iodine-123 SPECT/CT, Hanaoka K, Hosono M, Kurokawa T, Sakaguchi K, Yoshida S, Inoue R, Ishii K, Murakami T, Annual Congress of European Association of Nuclear Medicine,   2012 10 27
• Prediction of tumor response by Indium-111-Zevalin SPECT/CT and FDG-PET/CT in radioimmunotherapy for B-cell non-Hodgkin lymphoma, HOSONO Makoto, Annual Congress of European Association of Nuclear Medicine,   2012 10 27
• Radiation safety in Nuclear Medicine, HOSONO Makoto, 11th Annual General Meeting of Asian Regional Cooperative Council for Nuclear Medicine,   2012 10 24
• Infrastructure for Radionuclide Therapy, HOSONO Makoto, 52nd Annual Meeting of Japanese Society of Nuclear Medicine,   2012 10 , 招待有り
• PET and Radiation RIsk Communication, HOSONO Makoto, PET Summer Seminar 2012 in Shinshu,   2012 09 , 招待有り
• Chronological Documents on the Fukushima Accident-Nuclear Emergency at the Fukushima Nuclear Reactor Accident in March 2011, HOSONO Makoto, Annual Meeting of Society of Nuclear Medicine,   2012 06 09 , 招待有り
• Continuing Education for Certified Doctor "Guidelines", HOSONO Makoto, 12th Spring Congress of Japanese Society of Nuclear Medicine,   2012 04 28 , 招待有り
• Seminar for Young Specialists "Radionuclide Therapy", HOSONO Makoto, 12th Spring Congress of Japanese Society of Nuclear Medicine,   2012 04 27 , 招待有り
• Indium-111-Zevalin-SPECT/CT and FDG-PET/CT as quantitative evaluation in radioimmunotherapy for B-cell non-Hodgkin’s lymphoma, Annual Congress of the European Association of Nuclear Medicine,   2011 10 15 , Annual Congress of the European Association of Nuclear Medicine
• Measurement of functional thyroid weight using I-123 SPECT/CT as planning for radioiodine therapy, Hanaoka K, Hosono M, Shimosegawa E, Hatazawa J, EANM’11 annual congress of European Society of Nuclear Medicine,   2011 10 15
• A prospective Clinical Trial on Tumor Hypoxia Imaging with 18F-misonidazole (F-MISO) positron Emission Tomography (PET), Tachibana I, Nishimura Y, Shibata T, Kanamori S, Nakamatsu K, Tamura M, Koike R, Nishikawa T, Ishikawa K, Hosono M, 53rd annual meeting of ASTRO,   2011 10 02
• Clinical impact of CT attenuation correction by SPECT/CT in brain perfusion images, Ishii K, Hanaoka K, Okada M, Kumano S, Komeya Y, Tsuchiya N, Hosono M, Murakami T, SNM 2011 Annual Meeting,   2011 06 04
• The iliac wing sign: The feasibility for diagnosis of bone and/or soft-tissue injury of the pelvis and hips, Kakigi T, Hosono M, Shimono T, Hiraoka T, Nishimura K, ECR 2011,   2011 03 03
• FDG and F-MISO PET-CT in the treatment planning for radiation therapy., the First International Conference on Real-time Tumor-tracking Radiation Therapy with 4D Molecular,   2011 02 , the First International Conference on Real-time Tumor-tracking Radiation Therapy with 4D Molecular
• A Prospective Clinical Trial of Tumor Hypoxia Imaging with 18F-misonidazole (F-MISO) Positron Emission Tomography (PET), American Society for Radiation Oncology 53rd Annual Meeting,   2011 , American Society for Radiation Oncology 53rd Annual Meeting
• Definition of target volumes by PET/CT for radiation therapy planning using moving phantom, Hanaoka K, Hosono M, Okubo M, Usami K, Okumura M, Sumita M, Nishimura Y, Murakami T, EANM'10,   2010 10 09
• Measurement of regional cerebral blood flow associated with cilostazol tehrapy in vascular dementia., SNM2009 Annual Meeting,   2009 06 13 , ISM 2009 Annual Meeting
• Assessment of lymph node metastasis in esophageal cancer with SUV correction based on count recovery on 18F-FDG PET/CT., SNM2009 Annual Meeting,   2009 06 13 , SNM2009 Annual Meeting
• Malignant Lymphoma Post Therapy:Usefulness and Pitfalls Using FDG-PET/CT Compared to CT, MRI, and Ga Sxintigraphy., 94rd Radiological Society of North America,   2008 12 , 94rd Radiological Society of North America
• CT appearance of post OOKP procedure.,   2008 10
• Adrenal masses: The additional value of FDG-PET/CT for cancer patients, Okada M, Hosono M, Shimono T, Kumano S, Usami K, Yamazoe Y, Komeya Y, Kagawa Y, Tsuchiya N, Murakami T, 55th annual meeting of Society of Nuclear Medicine,   2008 06 14 , 55th annual meeting of Society of Nuclear Medicine
• Utility of partial volume correction based on count recovery on FDG PET/CT in lymph node metastasis of lung cancer, 55th annual meeting of Society of Nuclear Medicine,   2008 06 , 55th annual meeting of Society of Nuclear Medicine
• New insight into the pathogenesis of malignant lymphoma by integrated FDG-PET/CT, 55th annual meeting of Society of Nuclear Medicine,   2008 06 , 55th annual meeting of Society of Nuclear Medicine
• Evaluation of lymph node metastases in esophageal cancer with SUV correction for partial volume effect on FDG PET/CT, 55th annual meeting of Society of Nuclear Medicine,   2008 06 , 55th annual meeting of Society of Nuclear Medicine
• Static and moving phantom studies for treatment planning in an integrated PET/CT system., the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology,   2007 10 , the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology
• Effect of attenuation correction on wall motion quantification in Tl-201 ECG-gated myocardial SPECT. Assessment of lymph node metastasis in lung cancer with SUV correction based on count recovery in FDG PET/CT., 54th Annual Meeting of Society of Nuclear Medicine.,   2007 06 , 54th Annual Meeting of Society of Nuclear Medicine.
• Assessment of lymph node metastasis in lung cancer with SUV correction based on count recovery in FDG PET/CT., 54th Annual Meeting of Society of Nuclear Medicine.,   2007 06 , 54th Annual Meeting of Society of Nuclear Medicine.
• Abdominal calcifications: Pictorial review of liver, spleen, gallbladder, kidney, peritoneum, and vascular structure lesions, Im S, Okada M, Yoh T, Tsuchiya N, Hosono M, Murakami T, 92nd Scientific Assembly and Annual Meeting RSNA,   2006 11 26
• MR imaging, CT, and PET in patients with cancer of peritoneum and abdominal wall, Komeya Y, Okada M, Hosono M, Takeuchi R, Matsumura K, Murakami T, 92nd Scientific Assembly and Annual Meeting RSNA,   2006 11 26
• Biliary obstruction: Value of imaging for choledocholithiasis, pancreas, and bile duct cancer, Okada M, Im S, Yagyu Y, Shimono T, Murakami T, Hosono M, 92nd Scientific Assembly and Annual Meeting RSNA,   2006 11 26
• Hepatocellular carcinoma, cholangiocarcinoma, and liver metastasis by multimodality imaging: MSCT, US, MRI, and PET, Okada M, Yagyu Y, Murakami T, Numata K, Takeuchi R, Hosono M, 92nd Scientific Assembly and Annual Meeting RSNA,   2006 11 26
• PET first : Malignant Lymphoma., 92nd Radiological Society of North America.,   2006 11 , 92nd Radiological Society of North America.
• Early cancer diagnosis in healthy population, an epidemiological dilemma, Takeuchi R, Sengoku T, Okada M, Hosono M, Ohta H, Matsumura K, Annual Congress of EANM 2006,   2006 10 01
• Comparison of adrenal cortical scintigraphy, CT and chemical-shift MRI for differential diagnosis of adrenal cortical functioning adenoma, Yoh T, Hosono M, Tsuchiya N, Komeya Y, Hanada K, Im SW, Ashikaga R, Shimono T, Yagyu Y, Hiroi K, 53rd annual meeting of Society of Nuclear Medicine,   2006 06 03
• Difference of brain surface images between with and without attenuation correction for application to 3D-SSP technique, Hanada K, Hosono M, Hitomi Y, Yagyu Y, Komeya Y, Funatsu K, Takahashi E, Kudo T, Hitomi K, Nishimura Y, 53rd annual meeting of Society of Nuclear Medicine,   2006 06 03
• Quantitative assessment of wall motion and thickening on TL-201 stress myocardial gated SPECT for detecting ischemia, Komeya Y, Hosono M, Yoh T, Tsuchiya N, Hanada K, Ashikaga R, Yagyu Y, Koike R, Hiroi K, Kudo K, 53rd annual meeting of Society of Nuclear Medicine,   2006 06 03
• Quantification of left ventricular systolic and diastolic function using TL-201 gated SPECT and derivative analysis for detecting ischemia, Komeya Y, Hosono M, Yoh T, Tsuchiya N, Hanada K, Im SW, Ashikaga R, Yagyu Y, Okada M, Shimono T, 53rd annual meeting of Society of Nuclear Medicine,   2006 06 03
• Statistical image analysis of regional cerebral blood flow in patients of mild cognitive impairment and relation of MMSE subgroups, Hanada K, Hosono M, Hitomi Y, Yagyu Y, Komeya Y, Kitahata D, Ohga Y, Kudo T, Hitomi K, Nishimura Y, 53rd annual meeting of Society of Nuclear Medicine,   2006 06 03
• A case of granular cell carcinoma of the kidney,   2006 05
• Management of acute reactions to contrast media in kinki univ. medical hospital,   2006 04
• Management of acute reactions to contrast media in kinki univ. medical hospital,   2006 04
• Management of acute reactions to contrast media in kinki univ. medical hospital,   2005 10
• Correlation of regional cerebral blood flow and MMSE subgroups in patients of mild cognitive impairment, Hanada K, Hosono M, Hitomi Y, Yagyu Y, Kirime E, Komeya Y, Koike R, Kitahata D, Kudo T, Hitomi K, Nishimura Y, 52nd annual meeting of Society of Nuclear Medicine,   2005 06 18 , Society of Nuclear Medicine 52nd Annual Meeting
• Wall motion and thickening measurement on Tl-201 stress myocardial gated SPECT for detecting ischemia, Komeya Y, Hosono M, Kudo T, Koike R, Hiroi K, Yagyu Y, Hanada K, Nishimura Y, 52nd annual meeting of Society of Nuclear Medicine,   2005 06 18
• Assessment of left ventricular systolic and diastolic function using Tl-201 gated SPECT for detectiong ischemia, Komeya Y, Hosono M, Kudo T, Koike R, Hiroi K, Yagyu Y, Nin Seiun, Hanada K, Nishimura Y, 52nd annual meeting of Society of Nuclear Medicine,   2005 06 18
• Quantification of attenuation correction in Tl-201 myocardial SPECT,   2005 04
• Diagnostic effectiveness of Alzheiwer disease by 3D-SRT,   2004 11
• A trial to make a normal database of ^99mTc-HMPAO SPECT in Kinki University Hospital,   2004 07
• Different regional cerebral blood flow patterns in chronic schizophrenia with and without delusion, SNM,   2004 06 , SNM
• Wall motion quantification on Tl-201 gated SPECT for detecting ischemia, SNM,   2004 06 , SNM
• Regional CBF change and detection of vasospasm in subarachnoid hemorrhage, SNM,   2004 06 , SNM
• Disease severity and diagnostic performance of nuclear medicine physicians are not related in brain perfusion SPECT inpection for Alzheimer's disease,   2004 06
• Investigation of a diagnosis of Alzheimer disease by VOI classic,   2004 06
• Utility of 3D-SRT in a diagnosis of Alzheimer disease,   2004 04
• Regional cerebral blood flow in assessment of major depression and Alzheimer's disease in early elderly., Society of Nuclear Medicine 51nd Annual Meeting,   2004 , Society of Nuclear Medicine 51nd Annual Meeting
• Different regional cerebral blood flow patterns in chronic schizophrenia with and without delusion., Society of Nuclear Medicine 51nd Annual Meeting,   2004 , Society of Nuclear Medicine 51nd Annual Meeting
• Three-dimensional stereotacitc surface projection of brain perfusion SPET enhances diagnosis of Alzheimer’s disease,   2003 08
• Diagnostic performance of brain perfusion SPECT for Alzheimer's disease: comparison between visual interpretation and three-dimensional sterotactic surface display, SNM,   2003 06 , SNM
• Evaluation of regional CBF in subarachnoid hemorrhage using 99mTc-ECD, SNM,   2003 06 , SNM
• Isothiocyanato-dioxo-carboxymethyl-tetraazacyclotridecane as a new chelate to label antibody with technetium-99m, SNM,   2003 06 , SNM
• 201Tl SPECT and CT fusion in thoracic malignancy, SNM,   2003 06 , SNM
• Global cerebral blood flow changes measured by brain perfusion SPECT immediately after whole brain irradiation, ECNM,   2003 06 , ECNM
• Cerebral blood flow measurements by Tc-99m ECD and phase contrast MR, ECNM,   2002 09 , ECNM
• Brain perfusion SPET in Alzheimer’s disease has equivalent diagnostic power as MRI, ECNM,   2002 09 , ECNM
• Multiple marker image histogram analyses optimized for diagnostic performance: demonstration for SPECT lung V/Q, SNM,   2002 06 , SNM
• Detection of esophageal cancer and prediction of response to chemoradiotherapy, SNM,   2002 06 , SNM
• Quantitative measurement of regional pulmonary blood flow in normal volunteers, SNM,   2002 06 , SNM
• Comparison of cine phase contrast MR and 99mTc-ECD for quantification of cerebral blood flow, RSNA,   2001 11 , RSNA
• Regional cerebral blood flow quantification SPECT in aneurysmal subarachnoid hemorrhage, RSNA,   2001 11 , RSNA
• Accuracy of left ventricular ejection fraction determined by pFAST, PC-based software different from Germano’s method, for quantitative EKG-gated myocardial perfusion SPECT (QGS), RSNA,   2001 11 , RSNA
• Diagnostic performance of nuclear medicine physicians interpreting brain perfusion SPECT in Alzheimer’s disease and other dementias, RSNA,   2001 11 , RSNA
• Regional CBF quantification in aneurysmal subarachnoid hemorrhage, Hosono M, Machida K, Matsui T, Honda N, Takahashi T, Kashimada A, Shimizu Y, Osada H, Dei S, Ohmichi M, Asano T, ECNM,   2001 08 25 , ECNM
• Value of cerebral blood flow spet in dementia compared with magnetic resonance imaging, Machida K, Honda N, Hosono M, Shimizu Y, Kosuda S, Matsuda H, Ohshima M, Momose T, Koizumi K, Matsumoto H, Hashimoto J, Congress 2001 of European Association of Nuclear Medicine,   2001 08 25
• Detection of changes in regional CBF in subarachnoid hemorrhage using 99mTc-ECD, Hosono M, Machida K, Matsui T, Honda N, Takahashi T, Kashimada K, Shimizu Y, Osada H, Dei S, Ohmichi M, Ootawa N, Okada T, Nishimura K, Asano, T, 48th annual meeting of Society of Nuclear Medicine,   2001 06 23
• Fractal analysis for ventilation/perfusion ratio map in differentiating lung diseases, Dei S, Machida K, Honda N, Hosono M, Takahashi T, Kashimada A, Shimizu Y, Osada H, Ohmichi M, Ohtawa N, Takahashi M, Tanaka A, Thie JA, 48th annual meeting of Society of Nuclear Medicine,   2001 06 23
• Relationship between 99mTc-GSA scintigraphy and portal circulation in patients with hepatocellular carcinoma complicated by liver cirrhosis, Osada H, Machida K, Honda N, Hosono M, Takahashi T, Kashimada A, Shimizu Y, Watanabe W, Ohmichi M, 48th annual meeting of Society of Nuclear Medicine,   2001 06 23
• Creation of quantitative regional pulmonary blood flow map by concurrent use of MR angiograpy and perfusion SPECT, Honda N, Machida K, Osada H, Hosono M, Takahashi T, Kamano T, Kashimada A, Shimizu Y, Watanabe W, Dei S, Oomichi M, Usui Y, Hondo M, Okada T, Nishimura K, Ootawa N, Tanaka A, Takahashi M, 48th annual meeting of Society of Nuclear Medicine,   2001 06 23
• Inexpensive tool for quantification of left ventricular ejection fraction from gated-myocardial perfusion SPET, Machida K, Honda N, Hosono M, Shimizu Y, Nishimura K, Congress 2000 of European Association of Nuclear Medicine,   2000 09 02
• Changes of blood flow measured with Tc-99m ethyl cysteinate dimer in detection of vasospasm, Hosono M, Machida K, Matsui T, Honda N, Takahashi T, Kashimada A, Shimizu Y, Dei S, Ohmichi M, Asano T, Congress 2000 of European Association of Nuclear Medicine,   2000 09 02
• Quantification of cerebral blood flow with 99mTc ethyl cysteinate dimer for detecting vasospasm in aneurysmal subarachnoid hemorrhage, Hosono M, Machida K, Matsui T, Honda N, Takahashi T, Kashimada A, Shimizu Y, Osada H, Dei S, Toyoda H, Ohmichi M, Asano T, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• Interobsever variation in differential diagnosis of dementia by cerebral blood flow SPECT, Honda N, Machida K, Matsuda H, Ohshima M, Momose T, Matsumoto T, Hosono M, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• Myocardial wall thickening idex on 99mTc tetrofosmin gated SPECT for quantitative evaluation of regional wall motion, himizu Y, Machida K, Honda N, Hosono M, Takahashi T, Osada H, Toyoda H, Ohmichi M, Kato T, Maruyama Y, Tanaka S, Yoshimoto N, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• 99mTc-Pyrophosphate SPECT is more sensitive for functional recovery after acute myocardial infarction than rest/redistribution 201Tl SPECT, Shimizu Y, Machida K, Honda N, Hosono M, Takahashi T, Kashimada A, Osada H, Toyoda H, Watanabe W, Dei S, Ohmichi M, Ootawa N, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• Quantitative gated SPECT with 99mTc tetrofosmin is more accurate than echocardiography in determining left ventricular ejection fraction, Nishimura K, Machida K, Honda N, Hosono M, Takahashi T, Kashimada A, Shimizu Y, Osada H, Toyoda H, Watanabe W, Dei S, Ohmichi M, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• Detection of intrapulmonary shunting in liver cirrhosis by quantitative 99mTc MAA scintigraphy, Hosono M, Machida K, Honda N, Takahashi T, Kashimada A, Shimizu Y, Osada H, Dei S, Toyoda H, Ohmichi M, Ochiai K, Hondo M, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• Quantification of regional lung perfusion using 99mTc-MAA SPECT and cine phase contrast MR angiography, Osada H, Machida K, Honda N, Hosono M, Takahashi T, Kashimada A, Shimizu Y, Watanabe W, Ohmichi M, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• Ventilation/perfusion ratio maps with 99mTc-technegas and 99mTc-MAA in lung diseases, Dei S, Machida K, Honda N, Hosono M, Takahashi T, Kashimada A, Shimizu Y, Osada H, Toyoda H, Watanabe W, Ohmichi M, Ootawa N, 47th annual meeting of Society of Nuclear Medicine,   2000 06 03
• Quantitative evaluation of regional wall motion by a wall thickening index of gated Tc-99m-tetrofosmin myocardial perfusion tomography, Shimizu Y, Machida K, Honda N, Hosono M, Takahashi T, Takahashi T, Kamano T, Kashimada A, Osada H, Watanabe W, Dei S, Oomichi M, 46th annual meeting of Society of Nuclear Medicine,   1999 06 06
• Quantification of regional pulmonary arterial blood flow using Tc-99m-MAA SPECT and cine phase contrast MR angiography, Osada H, Machida K, Honda N, Takahashi T, Hosono M, Takahashi T, Kashimada A, Shimizu Y, 46th annual meeting of Society of Nuclear Medicine,   1999 06 06
• Ventilation SPECI is superior to CT ventilation map by non-radioactive xenon inhalation, Honda N, Machida K, Hosono M, Takahashi T, Takahashi T, Kamano T, Kashimada K, Osada H, Shimizu Y, Watanabe W, Dei S, Oomichi M, 46th annual meeting of Society of Nuclear Medicine,   1999 06 06
• mCBF quantification and SPECT for detecting vasospasm in patients with aneurysmal subarachnoid hemorrhage (SAH) using Tc-99m ethyl cysteinate dimer (ECD), Hosono M, Machida K, Honda N, Takahashi T, Takahashi T, Kashimada A, Osada H, Shimizu Y, Dei S, Toyoda T, Matsui T, Asano T, 46th annual meeting of Society of Nuclear Medicine,   1999 06 06
• Quantitative monitoring of cerebral blood flow (CBF) in patients with aneurysmal subarachnoid hemorrhage (SAH) with Tc-99m ethyl cysteinate dimer (ECD), Hosono M, Machida K, Honda N, Takahashi T, Takahashi T, Matsui T, 84th scientific assembly and annual meeting of RSNA,   1998 11 29
• Localization of small-cell lung cancer xenograft by two-step method with bispecific antibody and bivalent hapten, Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thédrez P, Faivre-Chauvet A, Machida K, Gautherot E, Barbet J, Chatal JF, Joint Congress of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology,   1998 08 30
• Detection of vasospasm in patients with aneurysmal subarachnoid hemorrhage (SAH) by non-invasive cerebral blood flow quantification, Hosono M, Machida K, Honda N, Takahashi T, Takahashi T, Dei S, Shimizu Y, Kamano T, Kashimada A, Osada H, Matsui T, Asano T, Joint Congress of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology,   1998 08 30
• Assessment of regional wall motion by gated myocardial perfusion tomography with 99mTc-tetrofosmin, Machida K, Honda N, Takahashi T, Hosono M, Takahashi T, Kamano T, Kashimada A, Osada H, Shimizu Y, Iwase T, Toyoda H, Ogawa K, Watanabe W, Dei S, Ohmichi M, Ohiai K, Takishima T, Joint Congress of the European Association of Nuclear Medicine and the World Federation of Nuclear Medicine and Biology,   1998 08 30
• Diagnostic abilities of high resolution CT, dynamic CT, and Tl-201 SPECT for evaluation of pulmonary masses, Kashimada A, Machida K, Honda N, Hosono M, Takahashi T, Takahashi T, Kamano T, Shimizu Y, Osada H, Iwase S, Toyoda H, Ogawa K, Watanabe W, Ohmichi M, Dei S, Ochiai T, 45th annual meeting of Society of Nuclear Medicine,   1998 06 01
• Utility of thallium-201 SPECT in determining site of image-guide biopsy for patients with thoracic tumor, Ogawa K, Machida K, Honda N, Takahashi T, Hosono M, Kamano T, Kashimada A, Shimizu Y, Osada H, Iwase S, Toyoda H, Watanabe W, Ohmichi M, Dei S, Ochiai T, 45th annual meeting of Society of Nuclear Medicine,   1998 06 01
• Flow patterns of ascending aorta in aortic regurgitation analysed by velocity-encoding MR imaging, Honda N, Machida K, Takahashi T, Kamano T, Hosono M, Kashimada A, 83rd scientific assembly and annual meeting of RSNA,   1997 11 30
• Spiral CT of stapes: spectrum of findings in normal and abnormal ears, Osada H, Machida K, Honda N, Takahashi T, Hosono M, Kamano T, 83rd scientific assembly and annual meeting of RSNA,   1997 11 30
• Transient hypersecretion of catecholamines associated with exacerbation of symptoms after I-131 MIBG therapy in patients, Sakahara H, Saga T, Yao Z, Nakamoto Y, Sato N, Hosono M, Endo K, Konishi J, 44th annual meeting of Society of Nuclear Medicine,   1997 06 01
• Simultaneous dual-isotope Tc-99m-tetrofosmin and Tl-201 SPECT in evaluation of primary lung cancer, Hosono M, Machida K, Honda N, Takahashi T, Kamano T, Kashimada A, 82nd scientific assembly and annual meeting of RSNA,   1996 12 01
• Portal flow measurement with velocity-encoding MR imaging in diffuse liver diseases, Honda N, Machida K, Osada H, Takahashi T, Hosono M, Kamano T, 82nd scientific assembly and annual meeting of RSNA,   1996 12 01
• Two-step targeting of medullary thyroid cancer by bivalent hapten and bispecific antibody in mice, Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thedrez P, Barbet J, Gautherot E, Machida K, Chatal JF, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Evaluation of three-head gamma camera SPECT images in 6 institutes, Hosono M, Machida K, Honda N, Matsumoto T, Togawa T, Yui N, Murata H, Maruno H, Hatano O, Uno K, Ohta M, Oyamada H, Kubo K, Ishii K, Nishimaki H, Horiike S, Matsunaga K, Mori Y, Iinuma T, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Targeting of small-cell lung cancer xenografts by Re-188-labeled monoclonal antibodies, Hosono MN, Hosono M, Mishra AK, Faivre-Chauvet A, Barbet J, Gautherot E, Knapp FF, Yamada R, Chatal JF, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Cinematic display of ECG-gated Tc-99m-tetrofosmin myocardial perfusion SPECT, Shimizu Y, Machida K, Honda N, Hosono M, Takahashi T, Kashimada A, Osada H, Iwase T, Toyoda H, Ogawa K, Watanabe W, Dei S, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Whole body scan by 3-head SPECT system: comparison of 3-projection Tc-99m-MDP bone scan with conventional 2-projection scan, Honda N, Machida K, Hosono M, Shimizu Y, Toyoda H, Sakurai K, Takahashi T, Kamano T, Kashimada A, Osada H, Iwase T, Watanabe W, Ogawa K, Dei S, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Evaluation of I-123 iomazenil SPECT for cerebrovascular disease:comparison with brain perfusion SPECT and brain MRI, Kashimada A, Machida K, Honda N, Hosono M, Takahashi T, Kamano T, Shimizu Y, Osada H, Iwase T, Toyoda H, Ogawa K, Watanabe W, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Preliminary study of measurement of regional pulmonary flow using MRI and Tc-99m-MAA lung perfusion scintigraphy, Osada H, Machida K, Honda N, Mamiya T, Takahashi T, Hosono M, Kamano T, Kashimada A, Shimizu Y, Iwase T, Toyoda H, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Value of Tl-201 and I-123-BMIPP dual energy cardiac SPECT in patients with chronic renal failure on hemodialysis, Toyoda H, Machida K, Honda N, Hosono M, Takahashi T, Kamano T, Shimizu Y, Osada H, Iwase T, Toyoda H, Ogawa K, Watanabe W, S Dei, Kasahara N, The 6th Asia and Oceania Congress of Nuclear Medicine and Biology,   1996 09 30
• Radioimmunodetection of medullary thyroid cancer by bivalent hapten and bispecific antibody in mice, Hosono M, Hosono MN, Kraeber-Bodéré F, Devys A, Thedrez P, Barbet J, Gautherot E, Machida K, Chatal JF, Congress 1996 of European Association of Nuclear Medicine,   1996 09 14
• Localization of small-cell lung cancer xenografts by Re-188-labeled monoclonal antibodies, Hosono MN, Hosono M, Mishra AK, Faivre-Chauvet A, Barbet J, Gautherot E, Knapp FF, Yamada R, Machida K, Chatal JF, Congress 1996 of European Association of Nuclear Medicine,   1996 09 14
• BMIPP and MIBG SPET finding in myotonic dystrophy, Honda N, Machida K, Hosono M, Mamiya T, Takahashi T, Kamano T, Kashimada A, Osaka H, Shimizu Y, Iwase T, Yoyoda H, Kinoshita S, Congress 1996 of European Association of Nuclear Medicine,   1996 09 14
• Preliminary study of measurement of focal pulmonary flow using MRI and 99mTc-MAA lung perfusion scintigraphy, Osada H, Machida K, Honda N, Mamiya T, Takahashi T, Hosono M, Kamano T, Kashimada A, Shimizu Y, Iwase T, Toyoda H, 43rd annual meeting of Society of Nuclear Medicine,   1996 06 03
• Targeting of small-cell lung cancer by octreotide labeled with I-125, In-111, and Re-188 in a mouse model, Hosono M, Hosono MN, Haberberger T, Zamora PO, Guhlke S, Bender H, Knapp FF Jr, Biersack HJ, Congress 1995 of European Association of Nuclear Medicine,   1995 08 26
• Imaging of small-cell lung cancer xenografts with I-125, In-111 and Re-188 octreotides, Hosono M, Hosono MN, Haberberger T, Zamora PO, Guhlke S, Bender H, Knapp FF Jr, Biersack HJ, 42nd annual meeting of Society of Nuclear Medicine,   1995 06 12
• Immunoscintigraphy of ovarian cancer using a monoclonal antibody to CA125, akahara H, Hosono M, Kobayashi H, Yao Z, Saga T, Yano S, Endo K, Mori T, Konishi J, 42nd annual meeting of Society of Nuclear Medicine,   1995 06 12
• Scintigraphic detection of colorectal carcinoma xenografts with Re-188 labeled monoclonal antibody, Hosono M, Hosono MN, Bender H, Zamora PO, Guhlke S, Knapp FF Jr, Biersack HJ, 6th World Congress of the World Federation Nuclear Medicine and Biology,   1994 10 23
• Improved biodistribution of radiolabeled biotinylated monoclonal antibody followed by the injection of avidin as a "chase", Kobayashi H, Sakahara H, Hosono M, Yao Z-S, Yamamuro T, Toyama S, Endo K, Konishi J, 6th World Congress of the World Federation Nuclear Medicine and Biology,   1994 10 23
• Localization of infiltration of human leukemia cells in SCID mice, osono M, Kondo A, Yao Z, Kobayashi H, Hosono MN, Sakahara H, Imada K, Okuma M, Uchiyama T, Konishi J, ongress 1994 of European Association of Nuclear Medicine,   1994 08 20
• Radioimmunotargeting with Re-188 labeled monoclonal antibody in mice bearing colorectal carcinoma xenografts, Hosono MN, Hosono M, Zamora PO, Guhlke S, Bender H, Biersack HJ, Onoyama Y, Ochi H, Konishi J, Congress 1994 of European Association of Nuclear Medicine, Düsseldorf,   1994 08 20
• Detection of proliferation sites of ATL cells in SCID mice, Hosono M, Kondo A, Yao Z, Kobayashi H, Hosono MN, Sakahara H, Imada K, Okuma M, Uchiyama T, Konishi J, 41st annual meeting of Society of Nuclear Medicine,   1994 06 05

Misc

• Myocardial changes on FDG‐PET/CT after radiation therapy for esophageal cancer, INADA Masahiro, FUKUDA Kohei, TATEBE Hitoshi, ISHIKAWA Kazuki, TACHIBANA Izumi, YOKOKAWA Masaki, NAKAMATSU Kiyoshi, KANAMORI Shuichi, NISHIMURA Yasumasa, HOSONO Makoto, 日本医学放射線学会総会抄録集, 74th, S189,   2015 02 28 , https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201502266110099109
• PET/CTシミュレーションにおける転移リンパ節の評価, 大久保充, 中松清志, 柴田徹, 金森修一, 西川龍之, 小池竜太, 立花和泉, 奥村雅彦, 西村恭昌, 細野眞, Japanese Journal of Radiology, 28, Supplement 1, 56,   2010 07 25 , http://jglobal.jst.go.jp/public/201002280021854072
• 肺癌・咽頭癌におけるPET/CTシミュレーション;転移リンパ節の評価, 大久保充, 中松清志, 柴田徹, 金森修一, 西川龍之, 小池竜太, 立花和泉, 奥村雅彦, 西村恭昌, 細野眞, 日本医学放射線学会総会抄録集, 68th, S226,   2009 02 28 , http://jglobal.jst.go.jp/public/200902226855206021
• PET/CTシミュレーションにおけるGTV描出のためのファントム実験, 大久保充, 中松清志, 柴田徹, 金森修一, 小池竜太, 廣井啓二, 奥村雅彦, 西村恭昌, 花岡宏平, 宇佐美公男, 細野眞, Radiat Med, 26, 46,   2008 04 25 , http://jglobal.jst.go.jp/detail.php?from=API&JGLOBAL_ID=200902267065155450
• PET/CTシミュレーションにおけるPET描出体積と肉眼的腫瘍体積との比較, 大久保充, 中松清志, 柴田徹, 金森修一, 小池竜太, 廣井啓二, 西村恭昌, 奥村雅彦, 細野眞, Radiat Med, 26, 52,   2008 04 25 , http://jglobal.jst.go.jp/detail.php?from=API&JGLOBAL_ID=200902299424273284
• PET/CTの放射線治療計画への応用:動体ファントムによる検討, 大久保充, 中松清志, 柴田徹, 金森修一, 小池竜太, 廣井啓二, 西川龍之, 奥村雅彦, 西村恭昌, 花岡宏平, 細野眞, 核医学, 45, 1, 54, 55,   2008 02 28 , http://jglobal.jst.go.jp/detail.php?from=API&JGLOBAL_ID=200902208237371269
• PET/CTシミュレーションにおけるFDG活性閾値設定の検討, 大久保充, 中松清志, 柴田徹, 金森修一, 西川龍之, 小池竜太, 廣井啓二, 奥村雅彦, 西村恭昌, 細野眞, 日本医学放射線学会総会抄録集, 67th, S258,   2008 02 28 , http://jglobal.jst.go.jp/detail.php?from=API&JGLOBAL_ID=200902229433304674
• 近畿大学病院における造影CT検査副作用への対応について, 土屋典生, 下野太郎, 足利竜一朗, 岡田真広, 柳生行伸, 米矢吉宏, 任誠雲, 葉輝明, 細野眞, 大久保充, 廣井啓二, 小池竜太, 中松清志, 金森修一, 柴田徹, 西村泰昌, Radiat Med, 25, 79,   2007 04 25 , http://jglobal.jst.go.jp/public/200902299334111390
• 動体ファントムを用いたPET抽出体積の検討, 大久保充, 中松清志, 金森修一, 小池竜太, 廣井啓二, 柴田徹, 西村恭昌, 奥村雅彦, 花岡宏平, 細野眞, 日本医学放射線学会学術集会抄録集, 66th, S332,   2007 02 28 , http://jglobal.jst.go.jp/public/200902246442995452
• 肺癌に対するPET/CTシミュレーションにおけるFDG活性閾値設定法の検討, 大久保充, 中松清志, 柴田徹, 金森修一, 小池竜太, 廣井啓二, 西村恭昌, 奥村雅彦, 細野眞, 日本放射線腫よう学会誌, 18, Supplement 1, 147,   2006 10 25 , http://jglobal.jst.go.jp/public/200902232151591450
• 放射性核種の免除レベルとクリアランスレベルの算出に関する考察, 細野 眞, 西村 恭昌, 粟井 和夫, 井上 正昭, 下野 太郎, 金森 修一, 柳生 行伸, 中松 清志, 花田 一志, 小池 竜太, 米矢 吉宏, 核医学, 40, 4, 507, 508,   2003 11

Awards & Honors

•   2020 04 , Kindai University Faculty of Medicine, Best Teacher Award (FY2018), Medical education
•   2019 11 , ICRP, Award to authors: ICRP Publication 140, Radiological protection in therapy with radiopharmaceuticals
•   2009 10 , Japanese Society of Nuclear Medicine, 48th Japanese Society of Nuclear Medicine Award
•   2008 12 , RSNA, Certificate of Merit, Malignant lymphoma post therapy: usefulness and pitfalls using FDG-PET/CT compared to CT, MRI, and Ga scintigraphy
•   2007 11 , RSNA, Certificate of Merit, Wide spectrum of malignant lymphoma: new insight into the pathogenesis of lymphoid malignancies in PET-CT and MRI
•   2006 12 , RSNA, Certificate of Merit, MR imaging, CT, and PET in patients with cancer of peritoneum and abdominal wall
•   1997 10 , Atomic Energy Research Foundation in Medicine, Award, Atomic Energy Research Foundation in Medicine

Research Grants & Projects

• Ministry of Health, Labour and Welfare, Workers' illnessclinical research project, Survey and research on the actual conditions of radiation exposure and reduction in radiation work in medicine
• Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Research on standards for radiation protection in conventional and innovative radiological practices
• Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Scientific Research (C), Dosimetry and personalized therapy in radionuclide therapy using novel nuclides
• Nuclear Regulatory Agency, Project for promotion of radiation safety regulations, Research on reasonable radiation management for short-lived alpha emitters
• Ministry of Health, Labour and Welfare, Ministry of Health, Labour and Welfare: Health and Labour Sciences Research Grants, Research on radiation protection for novel therapeutic procedures
• Ministry of Education,Culuture,Sports,Science and Technology, Grant-in-Aid for Scientific Research, Treatment of metastatic bone diseases by alpha-emitter Ra-223
• Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for Scientific Research(基盤研究(C)), Imaging of proliferative ability and hypoxia of tumor in radioimmunotherapy, In patients with CD20 positive B-cell non-Hodgkin lymphoma who underwent yttrium-90 labeled anti-CD20 ibritumomab tiuxetan therapy, glucose metabolism by FDG and hypoxia by FMISO were evaluated with PET/CT before and after therapy, and changes were analyzed over time. Antigen expression of CD20 was also evaluated by SPECT/CT using indium-111 labeled anti-CD20 antibody. Association of glucose metabolism, hypoxia, and CD20 expression with therapeutic response was analyzed.
• Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for Scientific Research(基盤研究(C)), Optimization of radioimmunotherapy with radiolabeled anti-HER2 antibody, Molecular targeting concept and technology have recently been established and applied to disease entities, and have proved efficient and indispensable in some pathological status. As one of molecular targeting applications, radioimmunoscintigraphy and radioimmunotherapy which use radiolabeled monoclonal antibodies recognizing malignancy have successfully been undertaken in laboratory studies and clinical applications. The purpose of this study was to develop tumor imaging and therapy using molecular targeting techniques. To conduct radioimmunotherapy with radiolabeled anti-HER2 antibody in patients, we investigated conditions of radiolabeling techniques of potentially therapeutic radionuclides and tumor-directed antibodies. Chelating agents having macrocycle structures are suitable for radioimmunotherapy because of conjugation stability. Parameters of radiolabeling for chelates have been determined and optimized in animal models with human cancers. Distributions of malignant cells were studied in animal models using radiolabeling of cancer cells. A liver metastasis model was constructed by injecting radiolabeled cancer cells into the portal vein or spleen. Biodistribution of cancer cells was determined by tracer studies using radiolabeled antibodies. The obtained data were used for analyzing parameters in forthcoming radioimmunotherapy. Basic safety standards in radiological protection were considered for prospects of radionuclide therapy in clinical facilities. In conclusion, our study demonstrates significant findings of basic investigation as molecular imaging and therapy are increasingly applied to clinical practices.
• Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for Scientific Research(基盤研究(C)), Radio immunotherapy of malignant tumors by pretargeting, The "affinity enhancement system", a two-step targeting technique using bispecific antibody and radiolabeled bivalent hapten, has been reported to be useful for the targeting of carcinoembryonic antigen-expressing tumors. The purpose of this study was to evaluate the efficacy of this method for targeting human small cell lung cancer using an antineural cell adhesion molecule antibody.Antineural cell adhesion molecule/antihistamine bispecific anti-body NKI NBLIJ79 was prepared by coupling an equimolecular quantity of a Fab' fragment of NK1NBL1 to a Fab fragment of antihistamine 679. Athymic mice inoculated with NC1-H69 small cell lung cancer cells expressing neural cell adhesion molecule were administered bispecific antibody and then 48 h later 1251-labeled bivalent histamine hapten. 1251-labeled in tact NKINBLI was injected into other groups of mice. Biodisributions were examined as a function of time.In mice of the two-step targeting, tumor-to-blood, tumor-to-liver and tumor-to-kidney ratios were 1.4 ± 1.1, 10.8 ± 13.2 and 4.6 ± 4.7, respectively, at 5 h, whereas 1251-labeled NK1NBL1 showed tumor-to-blood, tumor-to-liver and tumor-to-kidney ratios of 0.3 ± 0.1, 1.1 ± 0.2 and 0.9 ± 0.1, respectively, at 5 h. Dosimetry showed that tumor-to-liver and -to-bone marrow ratios of absorbed irradiation doses were 14.3 and 16.8 for the two-step method and 4.2 and 2.6 for the one-step method. This suggested that the affinity enhancement system could enhance the therapeutic potential of the antineural cell adhesion molecule antibody NK1NBL1.This two-step targeting method seems promising for the diagnosis and therapy of small cell lung cancer by giving enhanced tumor-to-normal tissue contrast.
• Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for Scientific Research(基盤研究(C)), Clinical efficacy of brain blood flow SPECT in the diagnosis of pochiatric disorders in the aged, Brain perfusion SPECT (BP-SPECT) has characteristic patterns of abnormality enabling differential diagnosis of dementia. The purpose was to measure inter-obserYer variations in diagnosis of dementia using BP-SPECT. BP-SPECT images of 57 cases, 19 of Alzheimer s Disease (AD) eight of multi-infarct dementia (MID), three of Pick's disease, five of other dementias and 22 normal controls, were interpreted by ten nuclear medicine physicians of variable experience before and after the addition of MRl. The physicians independently rated diagnoses that were listed beforehand according to a 5-point s...
• Ministry of Education, Culture, Sports, Science and Technology, Grants-in-Aid for Scientific Research(基盤研究(C)), EVALUATION OF ACCURACY OF SPECT IN THE DIAGNOSIS OF BRAIN TUMOR, Fifteen-four studies of ^<20l>T1 brain tumor SPECT were independently interpreted by 9 nuclear medicine physicians with and without reference magnetic resonance images in 2 separate sessions to define an effect of referring images, and inter-observer variations. The physicians were requested to detect foci of abnormal deposits, and to discriminate whether they were malignant or not according to 5-grade scaling of subjective diagnostic confidence. Receiver-operating characteristics (ROC) analysis was performed. Mean sensitivity for presence of lesions (SFP), and sensitivity and specifcity fo...